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Summary 
 
Vitamin E is a generic term for a group of micronutrients exhibiting the biological activity of 
α-tocopherol (αT). Initially, four tocopherols (T; α-, β-, γ-, δ-) and four tocotrienols (T3; α-, β-
, γ-, δ-) were recognized as the naturally occurring vitamin E compounds. The main 
difference among T and T3 is the 3-fold unsaturated 16-carbon side chain of the T3 compared 
to the saturated 16-carbon side chain of the T. Recently, a group of four vitamin E compounds 
with a single double bond at carbon 11' were discovered, namely tocomonoenols (T1). Edible 
oils are the major source of T, T3, and of T1. 
As a fat-soluble vitamin, the vitamin E is absorbed after oral intake and transported in the 
circulation to the liver, where vitamin E undergoes sorting by the action of the α-hepatic-
tocopherol transfer protein (TTP) and the cytochrome P450 (CYP) enzymes. αT is 
preferentially secreted into the bloodstream, while the non-αT congeners are metabolized by 
CYP to the carboxyethylhydroxychromanols (CEHC), which are excreted via urine and feces. 
The TTP has been recognized as necessary for the maintenance of normal αT concentrations 
in plasma and extrahepatic tissues. Interestingly, TTP might also protect the non-αT 
congeners from side-chain degradation, and therefore prevent their metabolic degradation. 
The present thesis aimed at increasing our knowledge of the non-αT congeners of vitamin E 
with respect to their occurrence in food, their intracellular localization upon uptake into liver 
cells, and their tissue distribution in mammals. A potential role of the TTP in the intracellular 
and intra-organismic trafficking of the non-αT congeners was a second focus of the current 
investigations. 
To this purpose, the vitamin E profiles and contents in oils of three Elaeis Guineensis, two 
Elaeis Oleifera, and one hybrid OxG palm fruit genotypes from Costa Rica were determined 
after mechanical extraction with a screw press and chemical extraction with hexane. Vitamin 
E profiles in the palm oils were similar, irrespective of the genotype and extraction procedure, 
and α- and γ-tocotrienols (αT3 and γT3) were the most abundant congeners. α-Tocomonoenol 
(αT1) was found in oils from five of the six varieties. Hexane extraction yielded up to 2.5-fold 
higher total vitamin E compared to screw press extraction. 
The two most abundant tocotrienols (αT3 and γT3) in the oils were selected for further studies 
with respect to their cellular uptake and intracellular distribution in cultured liver cells with 
and without stable expression of TTP and compared to their respective tocopherol 
counterparts (αT and γT). After uptake, all four congeners were primarily associated with the 
lysosomes, endoplasmic reticulum and plasma membrane. Overall, the results conclude that 
neither the structural differences between the four congeners, nor the TTP-expression are 
important factors behind the intracellular trafficking (uptake and distribution) of the 
congeners in cultured liver cells. 
Finally, an animal study was performed to examine the tissue distribution of αT1, which was 
found as a novel vitamin E congener during the characterization of the oils, in mice in 
comparison to αT. Besides was investigated the influence of TTP. Wild-type (TTP+/+) and 
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TTP knockout (TTP-/-) mice were fed a standard diet with either αT or αT1 for 2 weeks. 
Concentrations of αT and αT1 were measured in blood and several tissues. αT1 was only 
found in blood, not in tissues. Loss of TTP function in TTP-/- mice resulted in almost 
complete depletion of αT in all tissues. Interestingly, αT1, contrary to αT, was still present in 
blood of TTP-/- mice. In conclusion, αT1 reached the blood in mice with and without TTP 
function, suggesting that TTP may not, or only to a limited extent, be required for the 
secretion of αT1 into the systemic circulation. 
Overall, the findings of this thesis show that the non-αT congeners αT3 and γT3, have 
similarities with αT regarding the intracellular trafficking, whereas αT1 has different tissue 
and blood distribution compared to αT. The TTP lacks a significant role mediating the 
intracellular trafficking of αT and non-αT congeners. TTP is, however, involved in the 
secretion of αT from the liver into the bloodstream and might, to a certain extent, also be 
involved in the secretion of αT1. 
Based on the finding that the non-αT congeners represent the majority of vitamin E congeners 
in palm oils, the identification of additional food sources and a deeper understanding of the 
biological roles of these congeners is warranted. Since more is known about αT than the non-
αT congeners, new opportunities for further research on the biological activities and 
consequent health benefits of the non-αT congeners have arisen based on the contributions of 
the present thesis. 
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Zussamenfassung 
 
Vitamin E ist der Oberbegriff für eine Gruppe von Mikronährstoffen, welche die biologische 
Aktivität von α-Tocopherol (αT) aufweisen. Bisher wurden acht Kongenere, vier Tocopherole 
(T; α-, β-, γ-, δ-) und vier Tocotrienole (T3; α-, β-, γ-, γ-, δ-) als die natürlich vorkommenden 
Vitamin-E-Verbindungen klassifiziert. Die Unterscheidung zwischen T und T3 wird durch die 
dreifach ungesättigte 16-Kohlenstoff lange Seitenkette der T3´s im Vergleich zur gesättigten 
16- Kohlenstoff langen Seitenkette der T´s definiert. Vor kurzem wurde eine Gruppe von vier 
Vitamin-E-Verbindungen mit einer Einfach-Doppelbindung am 11ten Kohlenstoffatom 
entdeckt und als Tocomonoenole (T1) bezeichnet. Speiseöle sind die Hauptquelle für T, T3 
und T1. 
Das fettlösliches Vitamin E wird oral aufgenommen und zur Leber transportiert. In der Leber 
durchlaufen die Vitamin E Kongenere eine Sortierung durch das α-hepatischen-Tocopherol-
Transferprotein (TTP) und der Cytochrom P450 (CYP)-Enzyme. Das αT wird bevorzugt in den 
Blutkreislauf abgegeben, während die nicht-αT-Kongenere von den CYP-Enzymen zu den 
Carboxyethylhydroxychromanolen (CEHC) metabolisiert und über Urin und Stuhl 
ausgeschieden werden. Für die Aufrechterhaltung der normalen αT-Konzentration in Plasma 
und extrahepatischem Gewebe ist das TTP daher notwendig. Interessanterweise ist es 
möglich, das TTP auch die nicht-αT-Kongenere vor dem Abbau der Seitenkette schützen und 
so deren metabolischen Abbau verhindern kann. 
Ziel dieser Arbeit war unser Wissen über die nicht-αT-Kongenere von Vitamin E in Bezug 
auf ihr Vorkommen in der Nahrung, ihre intrazelluläre Lokalisation bei der Aufnahme in 
Leberzellen und ihre Gewebeverteilung bei Säugetieren zu erweitern. Die potentielle Rolle 
des TTP bei der intrazellulären Verteilung und dem Transport im Organismus der nicht-αT-
Kongenere war ein zweiter Schwerpunkt der aktuellen Untersuchungen. 
Zu diesem Zweck wurden die Vitamin-E-Profile und -Gehalte in Ölen von drei Elaeis 
Guineensis, zwei Elaeis Oleifera und einem hybriden OxG-Palmenfrüchte-Genotyp aus Costa 
Rica ermittelt. Die Öle wurden entweder mechanisch mit einer Spindelpresse oder chemisch 
mit Hexan extrahiert. Die Vitamin-E-Profile in den Palmölen waren unabhängig vom 
Genotyp und Extraktionsverfahren ähnlich, α- und γ-Tocotrienole (αT3 und γT3) waren die 
häufigsten Kongenere. α-Tocomonoenol (αT1) wurde in fünf der sechs Sorten gefunden. Die 
Extraktion mit Hexan ergab im Vergleich zur mechanischen Spindelpresse einen bis zu 2,5-
fach höheren Gesamt-Vitamin E-Gehalt. 
Aufgrund der aus den Ölen gewonnen Erkenntnisse bezüglich der Häufigkeit der 
vorkommenden nicht- αT-Kongenere, wurden die beiden Tocotrienole, αT3 und γT3, für 
weitere Studien auf ihre zelluläre Aufnahme und intrazelluläre Verteilung in kultivierten 
Leberzellen mit und ohne stabiler TTP-Expression ausgewählt und mit ihren jeweiligen 
Tocopherol-Gegenstücken, dem αT und γT, verglichen. Nach Aufnahme der vier Kongenere 
waren diese hauptsächlich mit den Lysosomen, dem endoplasmatischen Retikulum und der 
Plasmamembran assoziiert. Zusammengefasst lassen diese Ergebnisse darauf schließen, dass 
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weder die strukturellen Unterschiede, noch die Expression des TTP ausschlaggebende 
Faktoren für den intrazellulären Transport (Aufnahme und Verteilung) der Kongenere in 
kultivierten Leberzellen sind. 
Abschließend wurde eine Tierstudie durchgeführt, um die Gewebeverteilung des αT1, 
welches als neues Vitamin E Kongener bei der Charakterisierung der Öle festgestellt wurde, 
bei Mäusen im Vergleich zu αT untersuchen. Ebenfalls wurde hierbei der Einfluss von TTP 
mit berücksichtigt. Wildtyp (TTP+/+) und TTP Knockout (TTP-/-) Mäuse erhielten 2 Wochen 
lang eine Standarddiät mit αT oder αT1. Die Konzentrationen an αT und αT1 wurden im Blut 
und verschiedenen Geweben bestimmt. Das αT1 konnte ausschließlich im Blut, nicht in den 
Geweben, gefunden werden. Der Verlust der TTP-Funktion bei TTP-/- Mäusen führte zu einer 
fast vollständigen Abnahme der αT-Konzentrationen in allen Geweben. Interessanterweise 
konnte αT1, im Gegensatz zu αT, noch im Blut von TTP-/- Mäusen nachgewiesen werden. 
Das Vorhandensein von αT1 im Blut von Mäusen mit und ohne TTP-Funktion deutet darauf 
hin, dass TTP für die Sekretion von αT1 in den systemischen Kreislauf nicht oder nur 
eingeschränkt erforderlich sein könnte. 
Insgesamt zeigen die Ergebnisse dieser Arbeit, dass die nicht-αT-Kongenere αT3 und γT3, 
Ähnlichkeiten mit αT in Bezug auf den intrazellulären Transport besitzen, wohingegen αT1 
eine andere Gewebe-und Blutverteilungen aufzeigt. Das TTP scheint eine untergeordnete 
Rolle im intrazellulären Transport der Vitamin E Kongenere zu spielen. Es ist jedoch an der 
Sekretion von αT aus der Leber in den Blutkreislauf beteiligt und kann daher auch bis zu 
einem gewissen Grad an der Sekretion von αT1 beteiligt sein. 
Basierend auf der Feststellung, dass die nicht-αT-Kongenere die Mehrheit der Vitamin-E-
Kongenere in Palmölen repräsentieren, ist die Identifizierung zusätzlicher Nahrungsquellen 
und ein tieferes Verständnis der biologischen Rolle dieser Kongenere gerechtfertigt. Aufgrund 
des höheren Wissenstandes über αT im Vergleich zu den nicht-αT-Kongeneren, sind auf 
Grundlage der vorliegenden Arbeit neue Möglichkeiten für die weitere Erforschung der 
biologischen Aktivitäten und den daraus resultierenden gesundheitlichen Vorteile der nicht-
αT-Kongenere entstanden. 
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Chapter 1 
Introduction 
 
1. Vitamin E 
In the year 1922, Herbert Evans and Katherine Bishop reported for the very first time the 
existence of an unrecognized dietary factor essential for reproduction of rats, present in foods 
such as green leafy vegetables and butterfat, and capable of restoring the fertility of rats with 
proven sterility [1]. Its designation as vitamin came in 1925, named alphabetically as vitamin 
E, the fifth vitamin of the small family of vitamins discovered at that moment [2]. Years later, 
in 1936, Herbert Evans and his co-workers isolated from wheat-germ oil an alcohol exhibiting 
vitamin E activity and they proposed the name α-tocopherol, in agreement with their 
biological activity and chemical feature of alcohols (tokos = childbirth; phero = to bear; -ol, 
indicating an alcohol); besides they reported that after treatment of the α-tocopherol with 
methyl alcoholic silver nitrate, they convert the compound in another substance that exhibited 
a reduced vitamin E activity, leading them to conclude that vitamin E activity was not the 
property of one single compound [3]. 
 
1.1  Structures and stereochemistry 
Vitamin E is a generic term for a group of micronutrients exhibiting the biological activity of 
α-tocopherol (αT). The eight naturally occurring vitamin E compounds, four tocopherols (α-, 
β-, γ-, δ-) and four tocotrienols (α-, β-, γ-, δ-) consist of a chromanol head (with two rings; 
one phenolic and one heterocyclic) bound to a saturated phytyl (tocopherols) or threefold 
unsaturated isoprenoid (tocotrienols) 16-carbon sidechain. The assigned prefixes α, β, γ, or δ 
are based on the number and position of methyl groups substituted at the chromanol head 
(Figure 1).The phytyl side chain of the tocopherols (T) has three chiral centers at positions 2, 
4’ and 8’, which can be either in the R- or S- configuration, permitting eight different 
stereoisomers (RRR, RSR, RRS, RSS, SRR, SSR, SRS and SSS). Tocotrienols (T3) only have 
one chiral center at position 2, so they can have R-or S- configuration. However, the presence 
of double bonds at positions 3’ and 7’ on the isoprenoid side chain allows for the existence of 
four cis/trans geometrical isomers, leading at the end of theoretically eight isomers (R, cis-cis; 
R, cis-trans; R, trans-cis; R, trans-trans; S, cis-cis; S, cis-trans; S, trans-cis; S, trans-trans) 
[4].  
In addition to the T and T3, an emerging group of vitamin E compounds with the structural 
feature of a unique double bond at carbon 11' has been discovered, reported for the very first 
time in 1995 and named α-tocomonoenol (αT1) [5]. Years later, the congeners β-, γ- and δ- 
tocomonoenol where found and reported [6-8]. Besides, in 1999 an isomeric form of the αT1 
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with an unusual methylene unsaturation at the isoprenoid-chain terminus (carbon 12') was 
found in marine products and named marine-derived tocopherol (MDT) [9] (Figure 1). 
 
1.2  Occurrence and dietary intake 
Vitamin E is exclusively synthesized by photosynthetic organisms. T are the predominant 
congeners in higher plants and found in oil seeds, leaves, roots, tubers, cotyledons, 
hypocotyls, stems and flowers. T3 on the other hand are not usually found in the green part of 
the plants, their accumulation is mostly in seeds, the pericarp and specialized cells like latex 
tuber [10]. 
Edible oils are the major source of T and T3. αT is the predominant vitamer in sunflower, 
safflower, wheat germ, peanut and olive oils, while soybean, canola, sesame, corn and linseed 
oils contain high amounts of γ-tocopherol (γT). Recently, genetically modified sunflower oils 
with high contents of β- and δ-tocopherols have been developed. Important amounts of αT 
were also detected in seed oils of lemon, orange and tangerine; meanwhile γT was the most 
abundant in grape, guava, melon, tomato and pumpkin seed oils [11].  
Palm oil and rice bran oils are the first and second most abundant natural sources of T3, with 
γ-tocotrienol (γT3) as the most prominent vitamer. Wheat germ oils, cereal grains, such as 
oat, rye and barley, and tobacco seeds oil are also important sources of T3. α-Tocotrienol 
(αT3) is the predominant form in oat and barley. β-Tocotrienol (βT3) is the major vitamer in 
hulled and dehulled wheats [11-13]. 
Tocomonoenols (T1) have been detected in edible oils, fruits and leaves, such as αT1 in palm, 
pumpkin and sunflower oils [5, 6, 14]; γ-tocomonoenol in pumpkin oil [6]; δ-tocomonoenol in 
kiwi fruits [7]; and β-, γ- and δ-tocomonoenol in green leaves and etiolated beans of 
Kalanchoe daigremontiana and Phaseolus coccineus [8]. MDT was found in cold-water 
fishes, such as salmon and Antarctic notothenioid; as well as Antarctic krill (Euphausia 
superba) and phytoplankton [9, 15, 16]. 
Dietary intake recommendations for vitamin E from food, fortified food and multivitamins are 
based on the activity of the 2R-stereoisomeric forms of αT, because the RRR- is the form that 
occurs naturally in foods and is the most biologically active stereoisomer of all the naturally 
occurring vitamin E forms. Also the other three synthetic 2R-stereoisomers of αT exert a 
higher biological activity in comparison with the 2S-forms [17]. 
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Figure 1. Chemical structures of tocopherols, tocotrienols, tocomonoenols and the marine-
derived tocopherol. 
4 
 
The Institute of Medicine [17] in the US defined a Recommended Dietary Allowance for both 
men and women of 15 mg (35 μmol)/day of αT and for infants, children, and adolescents of 6-
15 mg (14-35 μmol)/day of αT. Even though a vitamin E deficiency is very rare, for adults an 
Estimated Average Requirement of 12 mg (28 μmol)/day of αT was estimated to achieve a 
sufficient protective effect of the vitamin E as antioxidant, and a Tolerable Upper Intake 
Level of 1000 mg (2325 μmol)/day of αT was established to avoid adverse effect of increased 
tendency to hemorrhage [17]. The European Food Safety Authority (EFSA) defined an 
Adequate Intake of 13 mg/day of αT for men, 11 mg/day of αT for women and 5-13 mg/day 
of αT for infants and children [18]. 
 
1.3  Absorption, distribution and metabolism 
As a fat-soluble vitamin, the route of vitamin E after oral intake follows in general the 
pathway of other lipophilic molecules and lipids. Even though the presence of lipid-rich foods 
is required for the absorption of vitamin E, some natural food ingredients as dietary fiber, 
plant sterols, eicosapentaenoic acid and retinoic acid, among others, can compete with the 
absorption of the vitamin E and limit is absorption rate, which varies from 20% to 80% [19]. 
The intestinal absorption starts with the secretion of pancreatic enzymes, bile acids, dietary 
lipids and vitamin E into the duodenum where all components interact to form mixed-micelles 
with the vitamin E embedded. Integrated in micelles, vitamin E is taken up into enterocytes by 
passive diffusion or receptor-mediated transport via the scavenger receptor class B type 1 
(SR-B1) and the Niemann-pick C1-like protein 1 (NPC1L1) [19]. In the enterocytes, vitamin 
E is incorporated into chylomicrons which are secreted into the lymphatic system mediated by 
the ATP-binding cassette (ABC) transporter subfamily A, member 1 (ABCA1) [18] (Figure 
2). 
The chylomicrons in the lymphatic system pass via the portal vain into the blood system, 
where they are hydrolyzed by lipoprotein lipase (LPL) to chylomicron remnants (CR) that 
transport vitamin E to the liver, where vitamin E is imported into the liver cells via low-
density lipoprotein receptor-related proteins (LRP) and low-density lipoprotein receptor 
(LDLR) (Figure 2). The extent of vitamin E absorption and transport to the liver is the same 
for all vitamers [19]. 
Once in the liver, vitamin E undergoes sorting mediated by the hepatic α-tocopherol transfer 
protein (α-TTP) (see section “α-tocopherol transfer protein”) or metabolic degradation via 
cytochrome P-450 (CYP) enzymes (see below), leading to almost exclusive secretion of αT 
into bloodstream [19]. So far, no specific plasma transport protein for vitamin E has been 
described, so the transport in the blood follows the lipoprotein transport route of other lipids 
that ends up distributing the vitamin E between the liver and extrahepatic tissues. 
αT is incorporated into very low-density lipoproteins (VLDL) and exported through ABCA1 
[20]. VLDL is enzymatically hydrolyzed by LPL resulting in the formation of low-density 
lipoproteins (LDL) that can incorporate αT back into liver or into extrahepatic tissues. From 
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extrahepatic tissues, αT is transported back to the liver in HDL, which are secreted involving 
ABCA1, where it can either be directly imported into the liver via SR-B1, or transferred to 
LDL mediated by the phospholipid transfer protein (PLTP) or cholesteryl ester transfer 
protein (CETP) [19] (Figure 2). 
 
 
Figure 2. Ingestion, absorption, distribution, metabolism and excretion of vitamin E. After 
ingestion, vitamin E follows in general the pathway of other lipids. Intestinal absorption starts with the 
pack of vitamin E into micelles, which are taken up by the enterocytes via receptors. Then vitamin E is 
incorporated into chylomicrons through an ABCA1 transporter, and transported into the blood 
circulation for distribution to the liver and extrahepatic tissues. This distribution occurs via 
chylomicrons remnants and lipoproteins. The vitamin E that enters the liver via receptors undergoes 
sorting mediated by the α-TTP or metabolic degradation via CYP. α-TTP discriminates in favor of αT, 
which protects αT from excessive metabolism and excretion, and instead mediate its secretion through 
an ABCA1 transporter back to bloodstream. Non-αT congeners are preferentially degraded in three 
phases, following the path of xenobiotic metabolism. Phase I is mediated by the CYP enzymes and 
produce specific metabolites, which are sulfated and glucuronidated by phase II enzymes. Free and 
conjugated metabolites are transported to kidney and bile through a phase III transporter; and excreted 
free or conjugated in urine and feces, or secreted via bile into the intestine for absorption. The figure 
was modified from [18, 19]. 
In the liver, all vitamers are degraded following the same catabolic pathway that leads to 
specific metabolites with an intact chromanol ring and differences in the side-chain. However, 
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the rate of degradation differs among vitamers due to differences in the chemical structure and 
nature of vitamin E source [21]. 
Studies carried out by Sontag and Parker [21] using the CYP4F2 tocopherol ω-hydroxylase, 
one of the CYP enzymes associated with the initial reaction of vitamin E metabolism, showed 
that the rate of metabolic degradation of the vitamin E congeners is mediated by two substrate 
structural features influencing the CYP4F2 activity, first the saturation of the side-chain and, 
to a lesser extent, the methylation pattern of the chromanol ring, with the desmethyl forms and 
tocotrienols being preferentially metabolized. 
The first step of vitamin E metabolism occurs in the endoplasmic reticulum of the 
hepatocytes. This ω-hydroxylation reaction, which is mediated by the CYP enzymes CYP3A4 
and CYP4F2, results in the formation of the long chain metabolite (LCM) 13'-
hydroxychromanol (13'-OH), which subsequently is ω-oxidized by alcohol and aldehyde 
dehydrogenase to the LCM 13'-carboxychromanol (13'-COOH). The LCM are transported 
into peroxisomes, probably via ABC transporters, as happens for very long-chain acyl-CoA 
molecules. Once in the peroxisomes, β-oxidation steps shorten the side-chain, with the 
elimination of propionyl-CoA or acetyl-CoA and formation of the LCM 
carboxydimethyldecylhydroxychromanol (CDMDHC or 11'-COOH) and 
carboxymethyloctylhydroxychromanol (CDMOHC or 9'-COOH). As the further side chain-
shortening steps take place in the mitochondria, the import of the LCM into mitochondria 
might occur through carnithin-acyl-transferase. Three β-oxidation steps take place in the 
mitochondria, producing the intermediate chain metabolites (ICM) 
carboxymethylhexylhydroxychromanol (CDMHHC or 7'-COOH) and 
carboxymethylbutylhydroxychromanol (CMBHC or 5'-COOH), and the catabolic end-
products or short-chain metabolites (SCM) carboxyethylhydroxychromanols (CEHC or 3'-
COOH) [19]. T3 experience a comparable catabolism as T, even if different LCM and ICM 
are formed, the resulting end-product is also the CEHC, leading to the conclusion that the 
side-chain of T3 is saturated before shortening mediated by the reductase and isomerase type-
enzymes [22] (Figure 3). 
The LCM, ICM and SCM are conjugated by phase II enzymes of xenobiotic metabolism, 
mainly via UDP-glucuronosyltransferases (UGT) and sulfotransferases (SULT), and therefore 
the metabolites appear either sulfated or glucuronidated. Due to their hydrophilicity, the SCM 
are excreted via urine, mainly in glucuronidated form. In parallel, all the conjugated or non-
conjugated metabolites of T and T3 are secreted via bile into the intestine and later eliminated 
via feces. In the feces, all the metabolites, T and T3 are excreted, and the LCM is the major 
metabolite present in percentages over 60%. So far, no specific transport proteins for 
conjugated or non-conjugated CEHC excretion have been reported, however, the phase III 
transporters multidrug resistance proteins (MDR3) are proposed as possible mediators in the 
elimination of the vitamin E metabolites [19] (Figure 2). 
αT is the predominant form found in human plasma with concentrations of 22-32 μmol/L, 
which are much higher than the concentrations found for γT (1,4-4,8 μmol/L) [23-25], βT 
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(~0,4 μmol/L) [23], δT (~0,3 μmol/L) [23, 24], and αT3, γT3 and δT3 (nearly undetectable, 
raising concentrations < 1 μmol/L after 8 days supplementation with 250 mg T3) [26]. 
 
 
Figure 3. Metabolic pathway of tocopherols and tocotrienols and the intracellular 
compartmentation of the different reaction steps. The metabolism of vitamin E is initiated with a 
CYP4F2/CYP3A4-dependent ω-hydroxylation in the endoplasmic reticulum, resulting in the 
formation of the 13′ hydroxychromanol. Next, a ω-oxidation leads to the formation of 13′ 
carboxychromanol, which is transported to the peroxisomes. Next, five cycles of β-oxidation 
shortened the chain and finally results in the formation of the carboxyethylhydroxychromanols 
(CEHC) in the mitochondria. T3 experienced a comparable metabolism as T, although they differ in 
the intermediate metabolites, the end product is the same. The figure was modified from [19]. LCM 
are named in blue, ICM in red and SCM in green. For the meaning of R1 and R2, referred to the box 
displayed inside the Figure 1. 
 
2. α-Tocopherol transfer protein 
α-Tocopherol transfer protein (α-TTP) is a cytosolic 32-kDa protein first described in 1975 as 
a component of rat liver cytoplasm [27]. Years later,  α-TTP was purified and characterized 
from rat liver [28, 29] and its cDNA isolated from human liver [30]. Hepatic α-TTP is 
required to maintain normal plasma and extrahepatic tissue concentrations of αT, its role starts 
after vitamin E is delivered into the liver, where α-TTP is able to preferentially binds and 
selectively retains αT over the others congeners, and furthermore mediates the intracellular 
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trafficking of αT until its secretion from the liver [31, 32]. Subsequent studies revealed the 
expression of α-TTP in other tissues as rat brain, spleen, lung, and kidney [33]; in rat uterus 
[34] and eye retina [35], suggesting that its expression in other organs regulates distinct 
tissue-specific accumulations of the vitamin E [32], and aims the maintenance of sufficient αT 
in sensitive tissues, i.e. the central nervous system and the developing embryo [20]. 
A key role of the α-TTP in regulation of vitamin E status was discovered after observation 
that humans suffering from ataxia with vitamin E deficiency (AVED) carry mutations in the 
TTPA gene that encodes α-TTP. AVED is a primary vitamin E deficiency where the lack of α-
TTP leads to an inability to discriminate between different forms of vitamin E, reflected in 
lower αT plasma concentrations and increased metabolism of αT and excretion of αCEHC. 
Clinical symptoms of AVED are characterized by a progressive spinocerebellar ataxia, 
dysarthria, loss of tendon jerks, decreased visual acuity, and impaired vibration sense, among 
others. Similar phenomena are observed in Ttpa knockout mice, were the generated absence 
of α-TTP produces the same symptoms observed in AVED patients, including primary 
vitamin E deficiency and spinocerebellar ataxia. Hence, the α-TTP knockout mice is an 
animal model to study the role of the α-TTP in vitamin E homeostasis [19, 32], or to 
investigate the specific roles of vitamin E congeners in different tissues, identify genes related 
with α-T in various diseases and for dissociate the antioxidant functions of the α-T from its 
other functions [36]. 
 
2.1  Structure, active site and affinity to vitamin E 
α-TTP is classified as a member of the SEC14-like protein family, characterized for being 
involved in lipid regulation. This family of proteins possesses a typical CRAL_TRIO lipid-
binding domain. The domain structure consists of five parallel β-strands constituting the floor 
of the binding pocket, a variable number of α-helices and a mobile helical gate at the 
carboxyl-terminal group that constitutes the entrance of the ligand to the binding pocket [37, 
38] (Figure 4). 
Crystallographic data showed the ligand-binding pocket of α-TTP mostly formed by 
hydrophobic amino acids, except for two serine residues and three molecules of water. When 
αT enters the binding pocket, the aromatic methyl group in 5-position of the chromanol ring 
fits perfect into a niche formed by the hydrophobic side-chains of the amino acids Ile194, 
Val191, Leu183, Ile154 and Ala156, establishing strong van der Waals interactions (Figure 
4). The other aromatic methyl groups in the 7- and 8-position, as well as the methyl at the 2-
position of the chromanol ring, make contacts to hydrophobic residues, Phe, Val, Leu and Ile, 
inside the cavity; and the phenolic hydroxyl group connects with the backbone carbonyl of a 
Val residue through a hydrogen bond. The prenyl side-chain folds into a U-shape, leading the 
methyl groups at 4'- and 8'-position in contact with Ile residues [37]. 
The relative affinities of the α-TTP for the different vitamin E congeners were reported as: 
RRR- αT, 100%; βT, 38%; γT, 9%; δT, 2%; SRR- αT, 11% and αT3, 12% [39]. 
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Figure 4. Structure of α-TTP (from X-ray data) bound to αT. Top panel: the four faces of the 
binding pocket are highlighted; the α-helix 6 (H6) in green (top), the β-strands floor of the cavity in 
yellow (bottom), the mobile helical gate in blue (front) and the inner core of the binding pocket (back). 
Inset panel: 3D rendering of αT bound to α-TTP, where the residues Ile194, Val191, Leu183, Ile154 
and Ala156 in van der Waals contacts with the aromatic methyl group in 5-position of the chromanol 
ring are highlighted in white and the interaction in dashed blue lines. Bottom panel: chemical structure 
of αT. The figure was taken from [38]. 
The presence of the methyl group in 5-position of the chromanol ring was proposed as the 
main reason for the selectivity of the α-TTP for αT. It was initially postulated that the absence 
of one methyl group reduces the surface available for hydrophobic interactions and 
diminishes the packing density into the binding pocket, and that this may be the reason why 
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even if the other tocopherols fit into the cavity as well [37], their relative binding affinities for 
the α-TTP are lower compared to αT [39]. However, more recently was reported that the 
Ala156 residue, forming part of the hydrophobic niche that surrounds the 5-methyl group, is 
the critical position behind the selectivity of the α-TTP for αT (Figure 4), since a mutant α-
TTP with modification in this residue preferentially binds to γT [38]. 
Another important feature determining α-TTP binding affinity is the R-configuration in the 2-
position of the chromanol ring, as observed in an in vivo experiment [40]. This is in 
agreement with the lower relative binding affinities of the SRR-stereoisomers of αT compared 
to the RRR-stereoisomers [39]. The position and interactions of the methyl groups of the 
prenyl side-chain inside the binding pocket were reported not to be a key factor on the α-TTP 
binding selectivity, most probably due to the fewer packing restraints and higher flexibility of 
the chain [37]. 
For the binding and unbinding of αT, the α-TTP undergo conformational changes in its 
binding pocket. A mobile helical surface segment acts as a lid sealing and opening the binding 
pocket. In the closed conformation, the hydrophobic residues of the lid are in direct contact 
with the side-chain of the αT. When the protein get in contact with the membrane, the 
residues in the positively charged cleft interact with the phosphate groups of the 
phosphatidylinositol 4,5-bisphosphate (PIP2). The interaction caused the open of the lid. The 
acyl chains of the PIP2 point toward the hydrophobic binding pocket, promoting a lipid 
exchange reaction in which the PIP2 in the membrane is exchange for αT. The α-TTP can 
therefore close the lid. The close conformation exposes a more polar face that facilitates its 
release from the membrane, followed by a transport inside the cells. This exchange of PIP2 by 
αT is reversible and when the two lipids are present in two different liposomes, α-TTP can 
transfer them in opposite directions [37, 41, 42]. 
 
2.2  Role on vitamin E transport and metabolism 
In vitro experiments with cultured hepatocytes expressing α-TTP revealed that the protein is 
not essential for the αT uptake from either HDL or LDL, leading to the conclusion that α-TTP 
action in the trafficking of αT inside the liver takes place in a later step [43]. 
Evidence was found that once αT enter the intracellular organelles; it is internalized into 
vesicles that end up in the endocytic compartment (late endosomes and lysosomes) where α-
TTP is localized, before being transported to the plasma membrane [43]. Later was reported 
that even though α-TTP is normally localized in late endosomes/lysosomes, its intracellular 
distribution changes in the presence of αT, which induces the protein to re-distribute 
throughout the cytosol. With the use of α-TTP mutants, was studied how the interactions of 
the protein with membrane lipids influence its role on trafficking. Results revealed that the 
hydrophobic surface on α-TTP (residues of Phe, Ile, Val and Met) are required for association 
of the protein with all membranes; whereas the 5-phosphoinositides in the plasma membrane 
selectively associate with the α-TTP binding pocket by contact with a positive patch of 
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residues on α-TTP surface (Lys and Arg), essentials for releasing of αT from the protein 
binding cavity to the membrane. According with the mutants used, the key residues for both 
interactions are the Phe169 and the Lys217, respectively [20]. 
These findings allowed the proposal of a mechanism for the role of α-TTP on αT trafficking 
in hepatocytes. Lipoproteins containing αT are endocytosed and reach the late 
endosomes/lysosomes, where the lipoprotein is degraded and αT is released [43]. The α-TTP 
binds to the recycling endosomes using the hydrophobic residues including Phe169. These 
endosomes are characterized by the presence of the CD71/transferrin and GTPase 
Rab8/transferrin receptors, important in the binding of αT in the recycling endosomes. α-TTP 
binds the αT in its hydrophobic pocket and together with the recycling endosome then 
translocate to the plasma membrane. α-TTP binds with the PIP2 through its positively charged 
residues including Lys217. This interaction causes a conformational change in α-TTP binding 
space that produces the exchange of αT by PIP2 (see section 2.1). αT in the plasma membrane 
exits through an ABCA1 transporter and associates with lipoproteins that deliver it to 
extrahepatic tissues. α-TTP travels back inside the cell to repeat the cycle. The directionality 
of the process is leading by the opposite concentration gradients of PIP2 (high at the plasma 
membrane) and αT (high at the endocytic vesicles) [20] (Figure 5). 
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Figure 5. Proposed mechanism underlying α-TTP role on αT trafficking in hepatocytes. αT 
enters the cell by endocytosis and reaches the recycling endosome and/or is storage in the late 
endosomes/lysosomes. In the presence of αT, the α-TTP associates with the recycling endosome 
through its hydrophobic region with Phe169, and then binds αT. The recycling endosome together 
with the α-TTP and αT then travel to the plasma membrane. α-TTP then associates with the PIP2 
through its positively charged residues with Lys217, and αT is exchange by the PIP2. Release αT exits 
the plasma membrane through an ABCA1 transporter and associates with lipoproteins. α-TTP 
translocate back inside the cell to repeat the cycle. Binding of αT is regulated by the CD71/transferrin 
and GTPase Rab8/transferrin receptors of the recycling endosome. Directionality of the process is 
provided by the opposite concentration gradients of PIP2 and αT. The figure was modified from [20, 
41]. 
In addition to α-TTP acting as a mediator of αT-trafficking inside the liver, previous research 
suggests that α-TTP might prevent the metabolic degradation of vitamin E congeners. In vitro 
experiments with hepatic α-TTP-expressing cells incubated with αT and/or γT, revealed a 
reduced γ-CEHC formation in α-TTP-cells, whereas an increase of the metabolite was 
observed with increasing αT concentration. Furthermore, in vivo experiments in wild-type and 
α-TTP knockout mice fed with equal doses of αT and γT in the absence or presence of 
sesamin (an inhibitor of vitamin E metabolism), revealed that the inhibition of metabolism 
increases γT concentrations in tissues, whereas the knockout of α-TTP reduces them [44]. 
The proposed model, based on these previous findings, suggests that the non-αT congeners, 
once they enter the liver, might be partly protected from side chain-degradation when bound 
to α-TTP. However, as the binding affinities of the non-αT congeners are lower than that of 
αT, the non-αT congeners are displaced from α-TTP binding in the presence of αT and 
become available for ω-hydroxylation again [44]. However, the above described protective 
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role of vitamin E from metabolic degradation is unlikely to be the primary role of α-TTP, but 
more likely a side effect of the binding affinities for several ligands. Furthermore, the 
metabolism and not α-TTP is primarily responsible for the discrimination between the vitamin 
E congeners [44], and the primary role of α-TTP seems to be the maintenance of adequate 
tissue concentrations by facilitating vitamin E secretion from the liver [18]. 
Curiously, the ability of the different vitamin E congeners to act as ω-hydroxylase substrates 
are for most of them the inverse of their binding affinities for the α-TTP, suggesting a 
collaborative role of the two proteins in the vitamin E homeostasis [21]. Besides, experiments 
using Drosophila melanogaster, an insect that naturally lacks of α-TTP expression, showed 
that it can selectively accumulates αT over the others vitamers by a mechanism involving 
CYP tocopherol ω-hydroxylase, respalding the crucial role of metabolism for the 
discrimination between vitamers and a separate evolution of the two hepatic mechanisms 
involved in vitamin E homeostasis [45]. 
This differences in rate degradation of the vitamin E congeners are supported by in vivo 
results, where after supplementation with a mixture of the different congeners, they appear in 
human plasma with half-lives in an increasing order of δT3 (2,3 h) < αT3 (4,3 h) ≤ γT3 (4,4 h) 
< γT (8-16 h) < αT (45-60 h) [19]. Besides, a study on the cytotoxicities of the different 
vitamin E congeners in murine macrophages and the elimination rates on hepatocytes, 
reported an inverse correlation between both parameters, underlying a physiological reason 
behind the different rates and degradation of the congeners [46]. 
 
3. Functions and health implications of vitamin E 
Soon after its discovery, in 1931 the antioxidant activity of αT was discovered and proposed 
as its major biological function [47]. Later on, other biological functions of the vitamin E, 
non-related with its antioxidant capacity, were discovered. The role of the vitamin E has been 
recognized on cellular signaling, gene regulation and catalytic activity of several enzymes 
[48, 49]. 
 
3.1  Antioxidant function of vitamin E: lipid-soluble radical scavenger 
Radical scavenging is one of the important functions of antioxidants. Free radicals are 
chemical species that contain one or more unpaired electrons. Several free radicals are 
constantly produced in the body as a result of physiological processes, as examples, reactive 
oxygen species (superoxide, hydroperoxide, peroxyl, hydroxyl, alcoxyl, aryloxyl), reactive 
nitrogen species (nitric oxide, nitrogen dioxide, peroxynitrites) and carbon centered radicals. 
Free radicals attack macromolecules such as lipids, proteins, carbohydrates and DNA; and 
start self-propagating radical chain reactions, which eventually damage the cells. Besides the 
macromolecules, these free radicals can react with other free radicals or antioxidants, to form 
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stable or much less reactive species. When the antioxidants in the body are unable to contain 
the free radicals produced, thus oxidative stress is induced [50]. 
There is well-documented evidence in vitro and some evidence in vivo that support the 
function of vitamin E as a peroxyl radical scavenger capable of preventing lipid peroxidation 
in cellular systems. In the presence of lipid peroxyl radicals, all vitamin E congeners break 
chain reactions, forming relatively stable lipid peroxides and tocopheroxyl radicals. 
Tocopheroxyl radicals are reduced back to the original vitamin E congeners by ascorbate 
(vitamin C) and by this means, prevent any potential pro-oxidant effect of the tocopheroxyl 
radicals on e.g. lipoproteins. Ascorbyl radical is regenerated with the support of the 
nicotinamide adenine dinucleotide (NADH)-dependent reductases (e.g. glutathione, 
dihydrolipoic acid, thioredoxin) [18, 48-50]. 
The peroxyl radical scavenger characteristic of the vitamin E congeners is due to their ability 
to donate hydrogen from the phenolic group on the chromanol ring. Since the phenolic moiety 
is similar among the vitamin E congeners, all are considered potent antioxidants [51]. 
However, in vitro, the reactivity of the congeners has been reported in the order: αT > γT ≈ βT 
> δT. These differences have been attributed to the hydrogen-donating ability of the 
congeners, which increases with the methylation of the chromanol ring [52]. 
T3 are reported to be more efficient peroxyl radical scavengers in vitro than T in liposomal 
membranes; presumably because the unsaturated side chain allows for a more uniform 
penetration, distribution and mobility in the lipid layers of the cell membranes. Thus, lead to a 
more efficient interaction with peroxyl radicals and a subsequent faster recycling by the co-
antioxidants in the membranes [12, 13, 51]. However, in vivo, the few studies conducted 
concluded that T3 are equally potent as T in terms of their antioxidant capacity. The lower 
bioavailability of T3 compared to the T, would lead to a reduced antioxidant activity in vivo, 
mostly because of their lower plasma and tissue concentrations [12]. 
In addition to its function quenching reactive oxygen species, the vitamin E congeners can 
also trap reactive nitrogen species, which are mostly formed endogenously by phagocytes and 
macrophages during inflammatory processes. δT and γT have been reported to be superior to 
αT in detoxifying nitrite oxide and peroxynitrites from membranes. This higher capacity of δT 
and γT seems to be related with the un-methylated 5-position at the chromanol ring that 
allows the trapping of the nitrogen species. αT possesses a methyl group at the 5-position and 
can therefore not efficiently trap reactive nitrogen species [49, 51, 53]. 
 
3.2  Non-antioxidant functions of vitamin E 
Roles of the vitamin E in processes of cellular signaling, gene regulation and enzyme activity 
have been recognized of importance in the past years. Recently, their long chain metabolites 
also appeared as molecules with specific and distinct biological activities. In the next 
paragraphs are summarized some non-antioxidants functions documented for the tocopherols, 
tocotrienols and long chain metabolites. 
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3.2.1 Non-antioxidant function of tocopherols 
αT, specifically, inhibits smooth muscle cells proliferation by regulation of the protein kinase 
C (PKC) activity. αT inhibits the PKC activity by inducing its dephosphorylation through the 
activation of protein phosphatase 2A (PP2A) [18, 48, 49]. The PKC inhibition by αT have 
been linked with improve in pathophysiological conditions such as inflammation, lipid 
deposition in aorta, diabetic vascular complications and platelet aggregation [48]. 
αT also decreases the release of the pro-inflammatory cytokine interleukin-1β (IL-1β) via the 
inhibition of the 5-lipoxygenase (5-LOX) catalyzed reaction [49]. Same function was reported 
for δT and γT in lung epithelial cells. αT, δT and γT also inhibited the production of the pro-
inflammatory prostanglandin E2 (PGE2) via suppression of the cyclooxygenase-2 (COX-2) 
activity in macrophages. Supplementation with γT or γT-rich mixed T was reported to 
decrease the formation of PGE2 via COX-2, and leukotriene B4 (LTB4) via 5-LOX inhibitions 
in models of acute allergic and colitis inflammation. Since pro-inflammatory mediators from 
COX-2 and 5-LOX pathways are recognized to contribute to cancer development, tocopherols 
have been proposed as potentially chemoprevention agents [51]. 
The regulation of gene transcription by vitamin E has been reported for various proteins. One 
of the earliest evidences was the inhibition of xanthine oxidase activity and of its production 
of reactive oxygen species [48]. αT up-regulated the expression of α-tropomyosin leading to 
reduced cell proliferation. Furthermore, αT inhibited the age-dependent increase of 
collagenase in human skin fibroblasts; and the proliferation of rat A7r5 smooth muscle cells. 
At a transcriptional level, αT down-regulated the expression of the scavenger receptors class 
A (SR-A) in macrophages and cluster of differentiation 36 (CD36) in smooth muscle cells 
[48, 49]. The down-regulatory effect on CD36 was also observed in the liver, where αT 
prevented diet-induced lipid accumulation, since the hepatic CD36 act as the major fatty acid 
transporter [54]. αT can bind to the family of tocopherol-associated proteins (TAP) and forms 
a complex capable of inhibiting the expression of the phosphoinositide 3-kinase γ (PI3Kγ). In 
in vitro studies, this inhibition has been shown to suppress prostate cancer cell growth [48]. 
αT and δT equally induce the expression of the hepatic messenger ribonucleic acid (mRNA) 
for the α-tocopherol transfer protein (α-TTP) [49]. Supplementation with a sufficient dose of 
αT/γT-mix indirectly down-regulated the expression of the mRNA for the hemeoxygenase-1 
(HO-1), contributing to a decrease in the oxidative stress in cells [55]. δT and γT up-regulated 
the expression of the peroxisome proliferator-activated receptor γ (PPARγ), a nuclear receptor 
that have been demonstrated as important for inhibition of cell proliferation and induction of 
apoptosis in breast cancer. Besides, δT and γT down-regulated estrogen receptor α (ERα) 
signaling, which may play a role in the inhibition of mammary tumorigenesis [53]. 
3.2.2 Non-antioxidant function of tocotrienols 
T3, especially αT3, have been associated with neuroprotective properties, among other 
reasons, due to their role as inhibitor of the 12-lipoxygenase (12-LOX) pathway and the 
signaling of the nuclear factor κB (NF-κB) [12]. 12-LOX predominates in the brain and 
catalyzes the oxidation of arachidonic acid to 12-hydroperoxy-eicosatetraenoic acid (12-
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HPETE), a precursor in the synthesis of pro-inflammatory leukotrienes. 12-HPETE is thought 
to be neurotoxic and has been also implicated in the pathogenesis of Alzheimer’s disease due 
to its role as retrograde messenger in learning and memory [12, 13]. 
αT3, γT3 and δT3 up-regulated the peroxisome proliferator-activated receptors α, γ and δ 
(PPARα, PPARγ and PPARδ). The activation of these receptors have been associated with 
improved body glucose utilization and insulin sensitivity of diabetic mice, highlighting a role 
of T3 as mediators of target genes against diabetes [11]. 
As well, the effectivity of T3 lowering serum total and LDL-cholesterol levels has been 
reported. T3 reduces the endogenous synthesis of cholesterol by inhibition of enzymatic 
activity of the 3-hydroxy-3-methylglutaryl-coenzime A (HMG-CoA) reductase through a 
post-transcriptional mechanism. This reduction in the cholesterol biosynthesis may thus 
protects against hypercholesterolemia and metabolic syndrome, which are considered risk 
factors for neurodegenerative diseases [12, 13]. 
3.2.3 Non-antioxidant function of long chain metabolites 
Recently, the long chain metabolites (LCM) of vitamin E metabolism, particularly α-13'-
hydroxychromanol (α-13'-OH) and α-13'-carboxychromanol (α-13'-COOH) from the 
catabolism of αT, have been proposed as a new class of regulatory metabolites with specific 
and distinct activity compared to the precursor αT. In human macrophages, α-LCMs 
decreased the uptake of oxidized low-density lipoproteins (LDL) and oxidized LDL-induced 
lipid accumulation, due to a decreasing in phagocytic activity. Besides, α-LCMs act as anti-
inflammatory agents by blocking the lipopolysaccharide (LPS)-induced up-regulation of the 
expression of nitric oxide synthase, COX-2 and IL-1β [18]. 
Recently has been reported a biological activity of α-13'-COOH that is not shared by αT, nor 
by γT, αT3 or the corresponding SCM. α-13'-COOH activated the nuclear receptor pregnane 
X receptor (PXR), which induces the protein expression and transport activity of the P-
glycoprotein on LS 180 intestinal cells [56]. 
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4. Aims of the doctoral dissertation 
Since its discovery as an essential nutrient for female fertility in rodents in 1922, most studies 
have focused on αT and comparably little is known about the intracellular trafficking and 
tissue distribution of non-αT congeners and novel vitamin E derivatives, such as the T1, and 
their sources.  
The first aim of the present thesis was to characterize food sources of non-αT forms of 
vitamin E. To this end, the vitamin E composition of Costa Rican palm oil from six varieties 
(three Elaeis Guineensis, two Elaeis Oleifera and one hybrid OxG genotype) and the impact 
of oil processing (mechanical vs. chemical extraction) on the vitamin E profiles were 
investigated for the first time. The hypothesis that tocotrienols are the major compounds in the 
palm oils and that the vitamin E concentrations differ between genotypes and extraction 
methods was tested (Chapter 2). 
The second aim of the thesis was to elucidate, for the first time, structure-activity 
relationships in the cellular uptake and intracellular distribution of αT, αT3, γT, and γT3 in 
cultured hepatocytes expressing α-TTP or not. The hypothesis that differences on the 
chemical structure between T and T3 and the presence of α-TTP are the key factors behind the 
intracellular trafficking was tested (Chapter 3).  
Finally, because α-tocomonoenol (αT1) was detected in palm oil, and encouraged by the 
novelty of this congener and the lack of information regarding its behavior in vivo, the third 
aim of the thesis was to study, for the first time, the tissue distribution of αT1 compared to αT 
in a rodent model with homozygous α-TTP knockout (TTP-/-) and α-TTP-expressing wild type 
(TTP+/+) mice. Using this knockout-mouse model, it was possible to explore the impact of α-
TTP on the tissue distribution of αT1. The hypothesis that αT1 differs in tissue distribution 
from αT was tested (Chapter 4). 
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Chapter 2 
Tocopherols, Tocomonoenols, and Tocotrienols in Oils of Costa Rican Palm 
Fruits: A comparison between Six Varieties and Chemical versus 
Mechanical Extraction 
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Supporting Figure 1. Genetic relationship between palm fruit genotypes used in the study 
according with information given by ASD Costa Rica. Genotypes studied are displayed in 
white boxes and their parents genotypes are in grey boxes. Each genotype is named using 
their name follow by their experiment number. 
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Supporting Figure 2. HPLC and GC-MS chromatograms of vitamin E compounds in palm 
oil Elaeis Guineensis Tanzania CB063B (black, GC-MS system 1), and the isolated fraction 
of αT1 (orange, GC-MS system 2). GC-MS analysis (on GC-MS system 2) confirmed the 
identity of αT1 (m/z 500.5). The GC-MS chromatograms for the collected fractions (shown in 
orange, GC-MS system 2) were obtained on a different GC and column than that for the palm 
oil (black trace, GC-MS system 1) and therefore the time scales and retention times differ 
between chromatograms. 
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Supporting Figure 3. Mean (error bars reflect standard deviations, n=6) α-tocopherol (A), β-
tocopherol (B), γ-tocopherol (C), δ-tocopherol (D), α-tocomonoenol (E), α-tocotrienol (F), β-
tocotrienol (G), γ-tocotrienol (H) and δ-tocotrienol (I) contents (μg/g oil) of palm oils 
extracted from Elaeis sp genotypes using screw press extraction (white bars) or chemical 
extraction with hexane (black bars). Significant differences between extraction methods are 
indicated by asterisks (*P < 0.05; **P < 0.01; ***P < 0.001). 
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Supporting Table 1. Mean concentrations (± standard deviation; n=3; all in μg/g) of tocotrienols, tocopherols and α-tocomonoenol in palm oils 
(PO) and their processing byproducts; residual peel (RP), residual press cake (RPC) and centrifugation byproduct; in Elaeis sp Deli Dami CB087F 
and Quepos CB9204 extracted with chemical extraction and screw press extraction.1 
Compound 
Deli Dami CB087F Quepos CB9204 
Chemical extraction Screw press extraction Chemical extraction Screw press extraction 
PO RP PO RPC CB PO RP PO RPC CB 
αT 89.4 ± 5.2 341.4 ± 65.9 122.7 ± 9.4 230.0 ± 5.4 107.2 ± 5.5 4.0 ± 1.4 9.6 ± 2.0 5.9 ± 0.5 17.9 ± 1.8 10.0 ± 2.0 
βT 0.63 ± 0.05 4.1 ± 0.5 0.72 ± 0.04 2.65 ± 0.05 0.61 ± 0.05 nd2 nd 0.04 ± 0.01 0.11 ± 0.02 0.09 ± 0.01 
γT 0.73 ± 0.06 8.2 ± 1.3 0.93 ± 0.04 2.5 ± 0.1 0.75 ± 0.03 0.15 ± 0.03 0.57 ± 0.09 0.48 ± 0.03 1.7 ± 0.2 0.74 ± 0.07 
δT nd 0.7 ± 0.1 0.09 ± 0.01 0.23 ± 0.01 0.08 ± 0.01 nd nd 0.03 ± 0.01 0.08 ± 0.01 0.05 ± 0.01 
αT13 1.4 ± 0.1 6.8 ± 1.2 1.57 ± 0.07 nd 1.2 ± 0.2 1.7 ± 0.6 2.6 ± 0.6 0.95 ± 0.07 2.7 ± 0.4 1.8 ± 0.3 
αT3 59.1 ± 3.7 135.6 ± 25.2 66.8 ± 4.5 88.8 ± 2.1 57.2 ± 5.0 48.0 ± 20.8 146.3 ± 19.3 19.3 ± 2.1 38.9 ± 5.9 27.8 ± 4.7 
βT3 3.79 ± 0.55 7.8 ± 0.9 3.8 ± 0.8 4.3 ± 0.1 2.4 ± 0.4 0.5 ± 0.2 1.6 ± 0.3 0.32 ± 0.10 0.35 ± 0.02 1.8 ± 0.3 
γT3 195.1 ±18.2 249.6 ± 44.4 184.4 ± 11.6 223.9 ± 5.7 161.6 ± 14.6 1090.4 ± 170.7 1742.0 ± 75.1 410.6 ± 17.6 489.3 ± 69.8 349.6 ± 8.7 
δT3 34.5 ± 3.7 46.0 ± 6.4 23.7 ± 0.8 36.6 ± 0.8 20.5 ± 1.8 48.0 ± 18.2 54.7 ± 6.4 10.7 ± 0.8 18.5 ± 1.0 14.2 ± 2.0 
Total T 90.8 ± 5.1 354.4 ± 67.7 124.4 ± 9.5 235.4 ± 5.5 108.6 ± 5.5 4.2 ± 1.4 10.2 ± 2.1 6.4 ± 0.6 19.8 ± 2.0 10.8 ± 2.0 
Total T3 292.5 ± 26.1 439.1 ± 76.8 278.7 ± 15.9 353.7 ± 8.4 241.7 ± 21.4 1186.9 ± 209.3 1944.6 ± 93.8 440.9 ± 18.8 547.1 ± 76.7 393.3 ± 13.2 
Total VE 384.7 ± 31.2 800.3 ± 145.1 404.7 ± 25.2 589.0 ± 13.8 351.6 ± 23.2 1192.7 ± 211.0 1957.3 ± 95.9 448.2 ± 18.9 569.5 ± 79.0 406.0 ± 15.1 
1Vitamin E congeners differ in molecular weight and thus similar weights do not represent similar numbers of molecules. 
2nd=not detected. 
3Expressed as α-tocopherol equivalents. 
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Supporting Table 2. Mean concentrations (± standard deviation; n=6; all in μg/g) of 
tocotrienols, tocopherols and γ -tocomonoenol in pumpkin seed oil (Cucurbita pep L.)1 
Compound Concentration in pumpkin seed oil [μg/g] 
αT 3.1 ± 0.5 
βT 1.8 ± 0.4 
γT 239.4 ± 9.7 
δT 6.8 ± 0.3 
γT12 78.8 ± 2.5 
αT3 3.6 ± 0.3 
βT3 1.0 ± 0.2 
γT3 42.0 ± 6.4 
δT3 0.61 ± 0.04 
Total T 251.0 ± 10.0 
Total T3 47.1 ± 6.4 
Total VE 377.0 ± 16.0 
 
1Vitamin E congeners differ in molecular weight and thus similar weights do not represent 
similar numbers of molecules. 
2Expressed as γ-tocopherol equivalents. 
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Supplementary figure 1. Representative Western blots of cell organelle markers for 
lysosomes (LAMP1), plasma membrane (Na+-K+-ATPase), endoplasmic reticulum (calnexin), 
peroxisomes (catalase) and mitochondria (COX IV) for the 11 subcellular fractions obtained 
from HepG2 cells. 
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Supplementary table 1. Mean concentrations (± standard error of the mean; n = 3) of α-tocopherol and α-tocotrienol in cell culture medium and 
cell lysates of HepG2 cells and HepG2 cells transfected with an empty vector (HepG2-EV) or an expression vector carrying the TTP cDNA 
(HepG2-TTP) at different times after incubation with 50 μmol/L of α-tocopherol or α-tocotrienol.1 
Time 
(h) 
Concentration in cell culture medium 
(μmol/L culture medium) 
Concentration in cells lysates 
(μmol/g cell protein) 
α-tocopherol α-tocotrienol α-tocopherol α-tocotrienol 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
0.5 8.4 ± 1.3b 2.4 ± 0.3a 4.7 ± 0.7a 1.7 ± 0.1a 3.9 ± 0.5a 3.8 ± 0.8a 1.4 ± 0.6a 0.9 ± 0.2a 0.6 ± 0.2a 0.0 ± 0.0a 0.0 ± 0.0a 0.0 ± 0.0a 
1 9.5 ± 1.2b 2.3 ± 0.4ac 4.8 ± 0.6c 1.4 ± 0.2a 3.9 ± 0.5ac 3.9 ± 0.8ac 1.0 ± 0.3a 1.4 ± 0.4a 0.9 ± 0.3a 0.0 ± 0.0a 0.0 ± 0.0a 0.0 ± 0.0a 
2 4.5 ± 0.3b 2.0 ± 0.3ac 4.3 ± 0.6b 1.7 ± 0.3a 3.8 ± 0.5bc 3.9 ± 0.8bc 1.1 ± 0.4a 2.0 ± 0.6a 1.0 ± 0.3a 0.5 ± 0.2a 1.5 ± 0.5a 0.8 ± 0.2a 
4 4.8 ± 0.8b 1.8 ± 0.2a 2.9 ± 0.4ab 1.4 ± 0.2a 3.7 ± 0.3ab 4.3 ± 1.1b 2.9 ± 0.9a 1.7 ± 0.4a 1.5 ± 0.2a 1.1 ± 0.3a 2.8 ± 0.8a 1.7 ± 0.6a 
6 3.5 ± 0.4a 2.0 ± 0.3a 3.0 ± 0.5a 1.8 ± 0.3a 3.4 ± 0.6a 3.6 ± 1.0a 5.2 ± 1.0b 1.5 ± 0.4a 1.7 ± 0.2a 3.8 ± 1.2ab 1.7 ± 0.4a 2.8 ± 0.6ab 
24 2.6 ± 0.4ab 1.9 ± 0.6ab 2.6 ± 0.3ab 1.3 ± 0.3a 3.0 ± 0.4ab 3.8 ± 0.9b 3.9 ± 0.3a 3.6 ± 1.3a 3.4 ± 0.2a 6.6 ± 2.2a 6.0 ± 1.8a 8.4 ± 2.8a 
48 2.4 ± 0.2ab 1.7 ± 0.4ab 1.7 ± 0.3ab 1.4 ± 0.2a 2.6 ± 0.5ab 3.4 ± 0.7b 5.9 ± 0.8a 3.8 ± 0.9a 2.9 ± 0.3a 9.0 ± 2.5ab 20.5 ± 6.2b 6.9 ± 1.8a 
72 2.2 ± 0.2ab 1.9 ± 0.5ab 1.5 ± 0.1a 1.3 ± 0.2a 2.6 ± 0.6ab 3.4 ± 0.7b 8.8 ± 1.6ab 6.5 ± 1.7ab 3.9 ± 0.5b 14.4 ± 2.8a 6.9 ± 1.4ab 9.4 ± 3.4ab 
1Comparison of means were performed separately for concentration of α-tocopherol and α-tocotrienol in cell culture medium and cells lysates, 
respectively. Differences between cells types and compounds at each given time were calculated with a one-way ANOVA using Tukey’s posthoc 
test. Values within a row (for a given compartment) not sharing a common superscript letter are significantly different at P<0.05. 
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Supplementary table 2. Mean concentrations (± standard error of the mean; n = 3) of γ-tocopherol and γ-tocotrienol in cell culture medium and cell 
lysates of HepG2 cells and HepG2 cells transfected with an empty vector (HepG2-EV) or an expression vector carrying the TTP cDNA (HepG2-
TTP) at different times after incubation with 30 μmol/L of γ-tocopherol or γ-tocotrienol.1 
Time 
(h) 
Concentration in cell culture medium 
(μmol/L culture medium) 
Concentration in cells lysates 
(μmol/g cell protein) 
γ-tocopherol γ-tocotrienol γ-tocopherol γ-tocotrienol 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
HepG2 
HepG2-
EV 
HepG2-
TTP 
0.5 2.6 ± 0.2bc 2.3 ± 0.3bc 2.0 ± 0.5c 10.3 ± 1.8a 7.3 ± 0.7ab 6.1 ± 1.1b 2.2 ± 2.2a 0.0 ± 0.0a 0.0 ± 0.0a 3.9 ± 1.3a 3.2 ± 1.9a 1.9 ± 0.4a 
1 1.8 ± 0.2b 2.0 ± 0.4b 1.6 ± 0.4b 14.0 ± 3.5a 6.6 ± 0.4b 5.5 ± 0.8b 1.5 ± 1.4b 0.0 ± 0.0b 0.0 ± 0.0b 12.1 ± 4.1a 3.8 ± 0.4b 2.3 ± 0.4b 
2 2.5 ± 0.5c 2.1 ± 0.3c 2.3 ± 0.3c 4.1 ± 1.0ac 7.3 ± 0.5b 5.9 ± 1.0ab 2.6 ± 2.6ab 0.04 ± 0.02b 0.08 ± 0.03b 6.0 ± 2.3ab 7.2 ± 1.0a 5.1 ± 0.8ab 
4 2.0 ± 0.1b 1.4 ± 0.5b 2.4 ± 0.1b 6.0 ± 0.4a 7.2 ± 0.4a 5.6 ± 0.8a 1.0 ± 1.0b 0.1 ± 0.1b 0.06 ± 0.04b 25.1 ± 12.3a 9.1 ± 1.0ab 10.4 ± 1.0ab 
6 2.0 ± 0.1bc 1.5 ± 0.4c 2.5 ± 0.1bc 10.3 ± 2.4a 7.5 ± 0.9a 6.6 ± 0.8ab 18.0 ± 2.3ab 0.5 ± 0.2c 0.9 ± 0.5c 35.2 ± 9.3a 14.2 ± 1.7bc 15.7 ± 2.0bc 
24 1.9 ± 0.1b 1.2 ± 0.3b 2.1 ± 0.1b 8.7 ± 2.2a 5.7 ± 1.5b 5.0 ± 0.5ab 17.3 ± 6.5b 1.4 ± 0.7b 0.9 ± 0.1b 50.9 ± 8.9a 16.4 ± 1.3b 14.2 ± 1.4b 
48 1.7 ± 0.1b 1.3 ± 0.3b 2.3 ± 0.1b 8.1 ± 2.3a 3.2 ± 0.7b 3.8 ± 0.5b 12.6 ± 4.8b 2.4 ± 0.4b 2.4 ± 0.8b 35.9 ± 9.1a 13.3 ± 1.2b 18.8 ± 4.9ab 
72 1.2 ± 0.2a 1.0 ± 0.3a 1.8 ± 0.4a 4.9 ± 2.6a 2.8 ± 0.4a 2.8 ± 0.4a 8.3 ± 2.3b 6.6 ± 2.2b 2.9 ± 0.7b 39.4 ± 11.2a 19.2 ± 5.9ab 28.4 ± 10.4ab 
1Comparison of means were performed separately for concentration of γ-tocopherol and γ-tocotrienol in cell culture medium and cells lysates, 
respectively. Differences between cells types and compounds at each given time were calculated with a one-way ANOVA using Tukey’s posthoc 
test. Values within a row (for a given compartment) not sharing a common superscript letter are significantly different at P<0.05. 
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Supplementary table 3. Percentage of α-tocopherol or α-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells. 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 1.3 25.0 0.0 8.0 1.3 1.0 0.0 0.7 1.3 1.0 0.0 2.0 1.3 4.1 0.0 0.3 1.3 0.9 0.0 0.8 
2 1.2 16.7 0.0 11.1 1.2 1.5 0.0 1.6 1.2 7.1 0.0 1.8 1.2 3.0 0.0 0.3 1.2 1.7 0.0 1.3 
3 1.5 9.9 0.0 17.9 1.5 1.0 0.0 0.9 1.5 7.8 0.0 1.3 1.5 2.3 0.0 0.3 1.5 1.3 0.0 1.0 
4 1.6 7.2 0.9 9.8 1.6 1.0 0.9 1.9 1.6 5.1 0.9 1.4 1.6 1.4 0.9 0.3 1.6 0.6 0.9 1.5 
5 1.4 7.0 0.0 7.9 1.4 1.3 0.0 5.5 1.4 4.6 0.0 3.3 1.4 1.2 0.0 0.8 1.4 0.7 0.0 1.7 
6 1.8 6.1 1.9 8.6 1.8 4.1 1.9 15.2 1.8 6.4 1.9 11.9 1.8 1.6 1.9 5.4 1.8 0.8 1.9 2.3 
7 3.7 7.6 24.3 9.2 3.7 24.5 24.3 43.2 3.7 9.6 24.3 26.2 3.7 4.3 24.3 12.1 3.7 1.6 24.3 14.9 
8 22.4 11.0 13.9 11.6 22.4 37.1 13.9 26.6 22.4 17.8 13.9 26.4 22.4 15.7 13.9 27.0 22.4 11.1 13.9 19.0 
9 36.7 5.9 25.5 6.9 36.7 18.7 25.5 3.1 36.7 19.2 25.5 15.9 36.7 23.0 25.5 20.5 36.7 37.1 25.5 37.4 
10 13.8 3.0 17.3 4.7 13.8 8.2 17.3 0.8 13.8 14.8 17.3 6.2 13.8 22.0 17.3 19.5 13.8 36.4 17.3 16.3 
11 14.8 0.6 16.3 4.2 14.8 1.6 16.3 0.6 14.8 6.6 16.3 3.6 14.8 21.4 16.3 13.6 14.8 7.8 16.3 3.9 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 4. Percentage of α-tocopherol or α-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells transfected with an empty vector (HepG2-EV). 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 0.1 13.9 0.3 10.1 0.1 1.1 0.3 1.6 0.1 0.3 0.3 0.5 0.1 1.1 0.3 0.4 0.1 0.3 0.3 2.3 
2 0.2 12.3 0.0 10.9 0.2 1.1 0.0 3.4 0.2 3.3 0.0 4.5 0.2 1.5 0.0 0.8 0.2 0.7 0.0 2.9 
3 1.1 7.4 0.8 8.5 1.1 2.3 0.8 1.0 1.1 8.8 0.8 3.7 1.1 1.6 0.8 1.3 1.1 0.6 0.8 2.7 
4 1.6 5.2 0.4 9.3 1.6 1.5 0.4 0.9 1.6 7.3 0.4 3.3 1.6 2.0 0.4 1.5 1.6 0.8 0.4 2.6 
5 1.0 6.0 0.5 10.3 1.0 1.2 0.5 1.6 1.0 6.1 0.5 2.9 1.0 2.0 0.5 1.6 1.0 1.7 0.5 2.8 
6 1.0 7.3 0.6 11.9 1.0 1.2 0.6 9.6 1.0 5.9 0.6 4.8 1.0 2.0 0.6 3.3 1.0 1.8 0.6 2.7 
7 1.2 7.7 13.3 16.1 1.2 2.1 13.3 55.3 1.2 6.2 13.3 17.5 1.2 2.2 13.3 14.7 1.2 1.6 13.3 7.6 
8 3.2 9.1 48.1 16.3 3.2 12.0 48.1 20.3 3.2 8.9 48.1 33.2 3.2 6.2 48.1 30.4 3.2 3.9 48.1 31.2 
9 25.3 21.2 19.0 3.8 25.3 60.7 19.0 4.5 25.3 19.1 19.0 19.7 25.3 23.9 19.0 22.9 25.3 29.9 19.0 33.0 
10 46.1 8.0 5.9 1.5 46.1 15.8 5.9 1.0 46.1 22.8 5.9 7.7 46.1 38.3 5.9 9.9 46.1 45.4 5.9 10.0 
11 
19.3 2.1 11.1 1.3 19.3 1.0 11.1 0.8 19.3 11.2 11.1 2.3 19.3 19.3 11.1 13.3 19.3 13.3 11.1 2.3 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 5. Percentage of α-tocopherol or α-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells transfected with an expression vector carrying the TTP cDNA (HepG2-TTP). 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 0.3 14.5 0.0 10.7 0.3 1.6 0.0 1.1 0.3 0.3 0.0 0.2 0.3 1.3 0.0 0.2 0.3 0.8 0.0 0.7 
2 1.2 13.4 0.0 8.6 1.2 3.8 0.0 2.3 1.2 3.8 0.0 3.5 1.2 2.1 0.0 0.4 1.2 0.8 0.0 0.8 
3 0.5 10.5 0.0 8.2 0.5 2.7 0.0 1.5 0.5 7.0 0.0 3.6 0.5 2.6 0.0 0.4 0.5 1.3 0.0 0.8 
4 1.4 9.5 0.0 7.0 1.4 1.7 0.0 1.3 1.4 6.1 0.0 3.4 1.4 3.0 0.0 0.5 1.4 1.2 0.0 0.8 
5 2.1 6.5 0.0 6.8 2.1 1.7 0.0 2.8 2.1 5.6 0.0 3.8 2.1 3.0 0.0 0.5 2.1 1.1 0.0 0.9 
6 2.3 7.0 1.2 9.3 2.3 1.9 1.2 6.9 2.3 5.7 1.2 6.5 2.3 3.5 1.2 1.5 2.3 1.1 1.2 1.0 
7 4.9 7.8 7.2 17.5 4.9 3.4 7.2 36.6 4.9 7.1 7.2 10.8 4.9 4.9 7.2 8.7 4.9 1.6 7.2 4.3 
8 4.8 9.8 18.9 16.3 4.8 10.0 18.9 34.3 4.8 12.4 18.9 21.8 4.8 10.2 18.9 20.1 4.8 4.8 18.9 17.3 
9 27.4 10.5 38.9 12.1 27.4 34.9 38.9 9.9 27.4 19.0 38.9 23.8 27.4 16.7 38.9 25.0 27.4 20.0 38.9 36.0 
10 30.7 8.4 18.2 2.2 30.7 32.9 18.2 2.1 30.7 22.0 18.2 15.1 30.7 28.6 18.2 21.4 30.7 41.0 18.2 31.2 
11 
24.4 2.2 15.6 1.3 24.4 5.4 15.6 1.3 24.4 11.1 15.6 7.5 24.4 24.0 15.6 21.3 24.4 26.4 15.6 6.3 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 6. Percentage of γ-tocopherol or γ-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells. 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 0.2 6.9 0.4 12.8 0.2 8.2 0.4 1.9 0.2 0.5 0.4 0.6 0.2 0.8 0.4 0.4 0.2 0.3 0.4 0.6 
2 0.7 6.3 1.4 9.3 0.7 7.4 1.4 1.9 0.7 1.6 1.4 5.1 0.7 0.5 1.4 5.4 0.7 0.4 1.4 0.7 
3 3.6 4.0 3.9 7.2 3.6 9.6 3.9 2.3 3.6 5.0 3.9 9.0 3.6 1.3 3.9 4.9 3.6 1.3 3.9 0.7 
4 4.3 7.4 1.4 6.4 4.3 10.8 1.4 2.1 4.3 12.1 1.4 4.7 4.3 1.9 1.4 2.5 4.3 2.0 1.4 0.5 
5 1.2 8.8 2.3 6.4 1.2 5.1 2.3 6.8 1.2 10.8 2.3 4.1 1.2 1.4 2.3 5.8 1.2 1.8 2.3 0.4 
6 1.2 8.0 2.8 7.2 1.2 4.4 2.8 23.2 1.2 8.2 2.8 4.3 1.2 1.5 2.8 6.6 1.2 1.9 2.8 0.4 
7 1.4 9.0 3.3 9.9 1.4 4.6 3.3 26.7 1.4 10.1 3.3 7.9 1.4 5.1 3.3 12.7 1.4 4.5 3.3 2.0 
8 3.7 11.1 5.3 9.8 3.7 8.4 5.3 17.7 3.7 10.0 5.3 8.9 3.7 11.2 5.3 21.4 3.7 9.1 5.3 2.5 
9 18.5 20.0 14.4 13.2 18.5 14.4 14.4 11.8 18.5 14.8 14.4 13.7 18.5 21.2 14.4 15.7 18.5 26.0 14.4 23.9 
10 41.0 13.9 41.8 12.9 41.0 20.9 41.8 4.0 41.0 14.0 41.8 26.0 41.0 29.2 41.8 17.5 41.0 31.7 41.8 57.1 
11 24.0 4.5 23.1 4.9 24.0 6.2 23.1 1.5 24.0 13.0 23.1 15.7 24.0 26.0 23.1 7.3 24.0 21.0 23.1 11.3 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 7. Percentage of γ-tocopherol or γ-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells transfected with an empty vector (HepG2-EV). 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 0.6 9.9 0.1 12.3 0.6 9.0 0.1 1.6 0.6 3.1 0.1 3.8 0.6 23.0 0.1 2.2 0.6 3.3 0.1 2.5 
2 1.9 10.8 1.9 9.4 1.9 15.2 1.9 2.6 1.9 7.7 1.9 7.1 1.9 5.2 1.9 0.9 1.9 4.7 1.9 2.2 
3 3.4 11.2 0.3 6.8 3.4 10.6 0.3 3.4 3.4 8.9 0.3 6.1 3.4 6.1 0.3 1.2 3.4 4.6 0.3 1.1 
4 1.6 7.8 0.6 7.4 1.6 8.3 0.6 6.8 1.6 6.9 0.6 5.4 1.6 3.5 0.6 2.8 1.6 2.6 0.6 1.3 
5 1.0 9.0 1.5 8.1 1.0 5.6 1.5 4.7 1.0 5.4 1.5 6.3 1.0 3.1 1.5 5.6 1.0 1.5 1.5 3.6 
6 1.7 8.6 1.9 8.6 1.7 5.8 1.9 3.0 1.7 4.6 1.9 6.3 1.7 3.4 1.9 9.3 1.7 1.4 1.9 4.9 
7 1.8 9.0 10.5 9.2 1.8 7.4 10.5 6.6 1.8 5.9 10.5 9.3 1.8 4.9 10.5 11.9 1.8 1.9 10.5 10.0 
8 6.2 11.0 7.9 10.1 6.2 18.0 7.9 30.8 6.2 9.3 7.9 12.4 6.2 20.2 7.9 17.2 6.2 8.5 7.9 13.2 
9 36.4 12.0 25.3 17.5 36.4 16.1 25.3 31.4 36.4 16.7 25.3 15.1 36.4 19.3 25.3 19.1 36.4 30.8 25.3 23.6 
10 31.5 8.2 26.1 7.4 31.5 3.3 26.1 8.1 31.5 19.0 26.1 13.8 31.5 9.0 26.1 20.7 31.5 28.5 26.1 30.2 
11 
13.8 2.7 24.0 3.1 13.8 0.8 24.0 1.0 13.8 12.6 24.0 14.4 13.8 2.4 24.0 9.0 13.8 12.1 24.0 7.4 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 8. Percentage of γ-tocopherol or γ-tocotrienol (Cn) and band intensity (BI) of cell organelle markers separated by density 
gradient centrifugation for HepG2 cells transfected with an expression vector carrying the TTP cDNA (HepG2-TTP). 
Fraction 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes 
(LAMP1) 
γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 
Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI Cn BI 
1 0.0 11.6 0.6 19.2 0.0 7.0 0.6 6.9 0.0 1.0 0.6 0.9 0.0 0.6 0.6 1.0 0.0 1.1 0.6 1.2 
2 2.7 10.5 2.0 12.1 2.7 4.9 2.0 5.8 2.7 4.0 2.0 6.0 2.7 0.5 2.0 4.9 2.7 1.3 2.0 1.0 
3 2.4 11.7 1.3 8.8 2.4 7.4 1.3 4.4 2.4 6.2 1.3 11.0 2.4 0.8 1.3 1.1 2.4 1.6 1.3 1.0 
4 1.2 8.9 0.9 7.8 1.2 8.7 0.9 7.1 1.2 7.8 0.9 5.0 1.2 1.0 0.9 0.8 1.2 1.2 0.9 0.6 
5 0.8 10.2 0.8 6.5 0.8 10.5 0.8 5.0 0.8 6.2 0.8 4.5 0.8 1.2 0.8 0.6 0.8 1.3 0.8 0.6 
6 1.9 9.5 0.6 5.6 1.9 8.3 0.6 8.1 1.9 7.8 0.6 3.6 1.9 2.4 0.6 0.9 1.9 1.5 0.6 0.6 
7 4.3 9.4 1.1 5.2 4.3 5.7 1.1 16.0 4.3 12.9 1.1 6.5 4.3 5.1 1.1 2.7 4.3 3.9 1.1 0.7 
8 11.1 7.3 3.0 6.6 11.1 16.2 3.0 27.9 11.1 19.2 3.0 7.7 11.1 10.4 3.0 18.1 11.1 9.9 3.0 7.0 
9 20.3 8.1 13.8 15.5 20.3 16.1 13.8 12.7 20.3 9.7 13.8 16.3 20.3 23.1 13.8 57.9 20.3 25.4 13.8 40.6 
10 40.2 8.0 34.4 22.9 40.2 9.7 34.4 5.2 40.2 17.5 34.4 26.4 40.2 29.8 34.4 11.4 40.2 36.4 34.4 43.4 
11 
15.1 4.8 41.5 2.2 15.1 5.6 41.5 1.1 15.1 7.8 41.5 12.1 15.1 25.0 41.5 0.7 15.1 16.5 41.5 3.3 
Data displayed in dark grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is in agreement with the maximum 
concentration of the compound; and data displayed in light grey boxes indicated that the maximum band intensity of the organelle marker in the fractions is not in 
agreement with the maximum concentration of the compound. 
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Supplementary table 9. Non-parametric Spearman´s rank order correlation between the percentage of α-tocopherol or α-tocotrienol and the 
percentage of band intensity of cell organelle markers separated by density gradient centrifugation for HepG2 cells and HepG2 cells transfected 
with an empty vector (HepG2-EV) or an expression vector carrying the TTP cDNA (HepG2-TTP). 
Cell type 
Correlation 
parameter 
Peroxisomes (Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes (LAMP1) 
α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 α-T α-T3 
HepG2 
rs 
1 -0.6000 -0.4513 0.7727 0.2559 0.7182 0.7583 0.7182 0.8328 0.6636 0.8886 
P value 2 0.0510 0.1635 0.0053 0.4476 0.0128 0.0068 0.0128 0.0015 0.0260 0.0003 
HepG2-
EV 
rs -0.08182 -0.009091 0.6273 0.3364 0.9727 0.6818 0.9545 0.9364 0.8182 0.5455 
P value 0.8110 0.9788 0.0388 0.3118 < 0.0001 0.0208 < 0.0001 < 0.0001 0.0021 0.0827 
HepG2-
TTP 
rs -0.4727 0.2479 0.7818 0.4958 0.8545 0.9439 0.9636 0.9249 0.8545 0.9439 
P value 0.1420 0.4624 0.0045 0.1209 0.0008 < 0.0001 < 0.0001 < 0.0001 0.0008 < 0.0001 
1 Spearman´s correlation coefficient (rs) ranges from -1 to +1, with perfect positive correlation at value +1.  
2 Correlations are significant at the 0.05 level (two tailed). 
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Supplementary table 10. Non-parametric Spearman´s rank order correlation between the percentage of γ-tocopherol or γ-tocotrienol and the 
percentage of band intensity of cell organelle markers separated by density gradient centrifugation, for HepG2 cells and HepG2 cells transfected 
with an empty vector (HepG2-EV) or an expression vector carrying the TTP cDNA (HepG2-TTP). 
Cell type 
Correlation 
parameter 
Peroxisomes 
(Catalase) 
Mitochondria 
(COX IV) 
Endoplasmic reticulum 
(Calnexin) 
Plasma membrane 
(Na+-K+-ATPase) 
Lysosomes (LAMP1) 
γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 γ-T γ-T3 
HepG2 
rs 
1 0.3455 0.1727 0.5909 0.2000 0.8636 0.9091 0.8909 0.7909 0.8909 0.7636 
P value 2 0.2993 0.6147 0.0609 0.5574 0.0012 0.0003 0.0005 0.0055 0.0005 0.0086 
HepG2-
EV 
rs 0.2091 0.1364 0.1182 0.4455 0.9455 0.9545 0.1909 0.7091 0.8545 0.7909 
P value 0.5393 0.6937 0.7345 0.1730 < 0,0001 < 0.0001 0.5765 0.0182 0.0015 0.0055 
HepG2-
TTP 
rs -0.7091 0.05455 0.1545 -0.1818 0.6455 0.9273 0.7909 0.4545 0.9636 0.7455 
P value 0.0182 0.8812 0.6538 0.5950 0.0368 0.0001 0.0055 0.1635 < 0,0001 0.0112 
1 Spearman´s correlation coefficient (rs) ranges from -1 to +1, with perfect positive correlation at value +1. 
2 Correlations are significant at the 0.05 level (two tailed) 
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Chapter 4 
The bioavailability of α-tocomonoenol in mice, contrary to α-tocopherol, is 
low but may also be controlled by the hepatic α-tocopherol transfer protein 
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Abstract 
 
Tocomonoenols are structurally related to the vitamin E family of compounds and are 
distinguished from the saturated tocopherols and threefold unsaturated tocotrienols by their 
characteristic single double bond at carbon 11' in the sidechain. The hepatic α-tocopherol 
transfer protein (TTP) has a higher affinity for α-tocopherol (αT) than for all other vitamin E 
congeners and is required for the maintenance of normal αT concentrations in blood and 
tissues. Its role in the tissue distribution of α-tocomonoenol (αT1) is currently unknown. We 
therefore investigated the tissue distribution of αT1 compared to αT in 2-3 months-old female 
wild-type (TTP+/+) and TTP knockout (TTP-/-) mice fed a diet with either αT or αT1 for 2 
weeks. Concentrations of αT and αT1 were measured in blood, small intestine, liver, lungs, 
heart, kidneys, spleen, adipose tissue, and brain. αT1 was only found in blood, not in tissues, 
at a concentration of ca. 40% of that of αT in TTP+/+ mice (0.186 ± 0.079 μmol/L). αT 
concentrations in TTP+/+ mice were in the order of adipose tissue > brain > heart > spleen > 
lungs > kidneys > small intestine > liver, and reached 0.560 ± 0.065 μmol/L in blood. As 
expected, loss of TTP function in TTP-/- mice resulted in almost complete depletion of αT in 
all tissues. Interestingly, αT1, contrary to αT, was still present in blood of TTP-/- mice. In 
conclusion, we found that αT1 is bioavailable and reaches the blood in mice, but does not 
accumulate in tissues. αT1 may not depend entirely on TTP function for its secretion in the 
systemic circulation. 
 
Keywords: 
α-tocopherol transfer protein knockout mice; α-tocopherol; α-tocomonoenol; adipose tissue; 
blood, liver; TTP; protein expression; depletion. 
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1. Introduction 
 
Vitamin E comprises eight structurally related lipid-soluble compounds composed of a 
chromanol ring attached to a saturated (tocopherols (T)) or threefold unsaturated (tocotrienols 
(T3)) 16-carbon sidechain; with the prefixes α, β, γ, or δ designating the number and position 
of methyl groups substituted at the chromanol ring [1]. 
A novel vitamin E derivative with the structural feature of a single double bond at carbon 11' 
was reported for the very first time in 1995, named α-tocomonoenol (αT1; Figure 1) [2], and 
later detected in palm, pumpkin, and sunflower oils [3-5]. 
From the gastrointestinal tract, all eight vitamin E congeners are absorbed and transported to 
the liver to a similar extent, but then the liver selectively secretes α-tocopherol (αT) into the 
bloodstream for distribution in the body, while the non-αT forms are preferentially 
metabolized via a cytochrome P450-dependent pathway [6]. It has been suggested that the 
selective retention of αT is the result of an interaction of the catabolic pathway with the 
hepatic α-tocopherol transfer protein (TTP) [7], a cytosolic protein that preferentially binds 
αT (100%) over the others congeners, β-tocopherol (38%), γ-tocopherol (9%), δ-tocopherol 
(2%) and α-tocotrienol (12%) [8]. 
TTP is expressed primarily in liver, but has been detected in other tissues as rat brain, spleen, 
lung, and kidney [9]; in rat uterus [10] and eye retina [11], suggesting that its expression in 
other organs regulates distinct tissue-specific accumulations of the vitamin [12]. 
Humans with mutations in the Ttpa gene encoding TTP develop ataxia with vitamin E 
deficiency (AVED) and are unable to maintain normal αT plasma concentrations [6, 12].  
Previous studies into the tissue distribution of αT alone or in combination with their 
homologues all-rac-αT, α-tocotrienol, γ-tocopherol and γ-tocotrienol reported a wide 
distribution of αT in blood and tissues, primarily in the liver, lungs, spleen and brain; the 
deletion of the Ttpa gene in mice (TTP knockout mice) leads to the depletion of αT from all 
tissues [7, 13-22].  
The uptake of dietary αT1 and its tissue concentration have hitherto only been studied in a 
single trial in mice, in which αT1 was detected in the liver and brain [23]. 
A deeper understanding of the tissue distribution and accumulation of αT1 and their 
regulation, potentially by TTP, is required to elucidate its potential to exert the biological 
activity of vitamin E in mammals. We therefore investigated the tissue distribution of αT1 and 
αT in wild-type and TTP knockout mice (TTP-/-) administered identical dietary doses for two 
weeks.  
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2. Materials and Methods 
 
2.1.  Test compounds and diets 
RRR-α-tocopherol (αT, ≥95%, CAS number 59-02-9, cat#KP5101) was from DSM 
(Grenzach, Germany) and R-α-tocomonoenol (αT1; ≥99.5% pure, extracted from vitamin E 
capsules as previously described [24]) was a kind gift from Prof. Dr. Walter Vetter (Institute 
of Food Chemistry, University of Hohenheim, Germany). αT and αT1 (165 mg each) were by 
separately dissolved in 1 mL of ethanol and mixed thoroughly in 275 g of vitamin E-stripped 
corn oil (Dyets, Bethlehem, PA, USA). The fortified oils were used in the preparation of 
semisynthetic standard rodent diet (vitamin E free standard diet, C1000; Altromin 
Spezialfutter GmbH & Co. KG, Lage, Germany) containing 5% oil and 30 mg/kg of αT 
respectively αT1. 
 
2.2.  Animal experiment 
All animal procedures were carried out in accordance with the FELASA guidelines for the 
care and use of laboratory animals and approved by the regional presidium Stuttgart (Baden-
Württemberg, Germany; trial no. V 342/17 BC). Forty-four female mice (2-3 months old, 
21.2 ± 0.6 g) from our colony at the University of Hohenheim were fed for two weeks the αT-
containing diet before twenty-two C57BL/6 wild-type mice (TTP+/+) and twenty-two 
homozygous TTP knockout mice (TTP-/-, genotype confirmed by PCR) were randomized into 
four groups of 11 animals and animals from each genotype were fed the vitamin E free 
standard diet (modified C1000; Altromin Spezialfutter GmbH & Co. KG, Lage, Germany) 
fortified with either 30 mg/kg of αT or αT1. Concentrations of αT and αT1 in the diets were 
confirmed by HPLC and were ≤ 1 mg/kg of αT or αT1 (see Supplementary Figure 1). Mice 
were housed in groups of maximum 4 per cage in a controlled environment (22 ± 2 °C, 55 ± 
10% humidity, 12 h light/dark cycle) and had free access to feed and water. After 2 weeks, 
animals were fasted for 12 h, anaesthetized with CO2, and killed by cervical dislocation. 
Blood was collected into heparinized tubes, and tissues (small intestine, liver, lungs, heart, 
kidneys, spleen, adipose tissue and brain) were excised and snap-frozen in liquid nitrogen. All 
samples were immediately stored at -80 °C until further analysis. 
 
2.3.  HPLC analysis 
All chemicals used were of highest purity and purchased from Sigma-Aldrich (Taufkirchen, 
Germany), JT Baker (Phillipsburg, United States) or Merck (Darmstadt, Germany). Methanol 
was HPLC gradient grade and water was deionized and filtered (Millipore, Billerica, MA, 
USA). αT and αT1 were extracted from tissues (200 mg) and whole blood (100 µL) and 
saponified as previously described [25]. Prior to HPLC analysis, extracts were re-suspended 
in 100 μL methanol/water (85:15, v/v) and transferred to amber HPLC vials. Twenty 
microliter of the extract was injected into a Jasco HPLC (system controller LC-Net II/ADC, 
two pumps X-LCTM 3185PU, mixing unit X-LCTM 3180MX, degasser X-LCTM 3080DG, 
autoinjector X-LCTM 3159AS, column oven X-LCTM 3067CO, fluorescence detector FP-
2020 Plus; Jasco, Germany). Test compounds were separated on a Phenomenex KinetexTM 
PFP column (2.6 μm particle size, 150 x 4.6 mm) maintained at 40 °C, using methanol/water 
(85:15, v/v) at a flow rate of 1.7 mL/min, for a total run of 15 minutes. The fluorescence 
detector was operated at excitation/emission wavelengths of 296/325 nm, peaks were 
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recorded and integrated using Chrompass software (version 1.9. 302.1124, Jasco), and 
quantified against external standard curves using the authentic compounds. 
 
2.4.  GC/MS analysis 
To confirm the presence or absence of αT and αT1, crude extracts of liver samples were 
redisolved in 500 µL n-hexane, treated by column chromatography for purification and 
analyzed by gas chromatography with mass spectrometry (GC/MS) as previously described 
[24]. 
 
2.5.  Western blot analysis for TTP expression 
Liver protein homogenates were prepared in radioimmunoprecipitation assay buffer (Tris, 50 
mM; NaCl, 150 mM; sodium dodecyl sulfate (SDS), 0.1%; sodium deoxycholate, 0.5%; 
Triton X100, 1%; EDTA, 20 mM (pH 7.2); dithiothreitol, 1 mM; protease inhibitor cocktail 
(Sigma-Aldrich, Taufkirchen, Germany)) and stored at -80 °C until further analyses. The 
amount of protein in the supernatant was determined via Bradford assay [26] and 40 μg of 
protein per lane was separated by 10% SDS gel electrophoresis and transferred to 
polyvinylidenefluoride (PVDF) membranes, blocked for 1 h at room temperature in blocking 
buffer (5 % bovine serum albumin (BSA; Sigma-Aldrich, Taufkirchen, Germany) in tris-
buffered saline Tween-20 (TBST: 0.8 % (w/v) NaCl, 0.24 % (w/v) Tris-HCl (pH 7.6), 0.05 % 
(v/v) Tween 20 in H2Odd; Sigma-Aldrich, Taufkirchen, Germany)) and incubated with the 
primary antibodies (TTP (1:1000, ab155323); β-actin (1:1000, #4967, Cell Signaling 
Technology, Danvers, USA)).  
The primary antibodies were diluted in 5% BSA in TBST and incubated overnight at 4 °C. 
Membranes were washed three times with TBST and incubated for 1 h at room temperature 
with the secondary antibody (goat anti-rabbit peroxidase conjugated (1:10000, cat#401353, 
Calbiochem/Merck Millipore, Darmstadt, Germany)). Membranes were washed three times 
with TBST and bands visualized using AceGlowTM Essential chemiluminescence solutions 
A and B (Peqlab Biotechnologie GmbH, Erlangen, Germany) and 20X LumiGLO® Reagent 
and Peroxide Solutions (Cell Signaling Technology, Cambridge, UK), and intensities were 
recorded on a Fusion FX imaging system and band intensities were quantified using the 
FusionCapt Advance software (Vilber Lourmat, Eberhardzell, Germany). Expression of the 
protein α-TTP was tested using the housekeeping protein β-actin as loading control. 
 
2.6.  Statistical analysis 
Statistical analyses were performed using GraphPad Prism 5 (GraphPad Software, San Diego, 
CA, USA). Differences between group means were calculated by One-way Analysis of 
Variance with a Tukey’s multiple comparison test or by unpaired t-test with Welch’s 
correction (heterogeneity of variances). Reported values represent means ± standard error of 
the mean (SEM). Differences were considered significant at P<0.05. 
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3. Results and discussion 
 
To investigate the tissue distribution of αT1 and its regulation by TTP, we fed 2-3 months-old 
wild type (TTP+/+) and TTP knockout mice (TTP-/-, Figure 2) diets containing 30 mg/kg αT1 
or αT for two weeks. No significant differences in body weight gain, final body weight, and 
absolute and relative (referred to body weight) organ weights were observed between the 
experimental groups (data not shown), indicating a normal, healthy and comparable 
performance of the mice during the experiment.  
To the best of our knowledge is the first time that the presence of αT1 is reported in the blood 
of TTP+/+ and TTP-/- mice. In a previous mouse trial, αT1 was found in the liver and brain, but 
in agreement with our findings, not in the lung and spleen [23]. 
αT was present in the blood and all examined tissues, with the exception of the liver, of 
TTP+/+ mice fed αT or αT1 (Figure 3). Interestingly, αT concentrations in the blood of TTP+/+ 
mice fed αT1 were numerically higher, but not significantly different, than in the TTP+/+ mice 
fed αT (Figure 3H). αT was also present in αT1-fed mice, probably because all animals 
received αT-containing diets until the beginning of the trial, and the short duration of the trial 
did not result in a depletion of αT in the tissues. Another potential explanation, which could 
also partly explain this and thus deserves further investigation, is the conversion of αT1 to αT 
by the saturation of the side-chain. Such a side-chain saturation would be in line with the 
observed concentrations of αT in the blood and tissues of TTP+/+ mice fed αT1. Earlier 
investigations reported that the metabolism of tocotrienols involves enzymes, probably 2,4-
dienoyl-coenzyme A-reductase, that catalyze the saturation of the side-chain, similar to those 
involved in the β-oxidation of unsaturated fatty acids [27]. 
αT concentrations in αT-fed TTP+/+ mice were in the order of adipose tissue > brain > heart > 
spleen > lungs > kidneys > small intestine > liver, and reached 0.560 ± 0.065 μmol/L in blood 
(Figure 3). αT1 was only found in blood, not in tissues, at a concentration of ca. 40% of that 
of αT in TTP+/+ mice (0.186 ± 0.079 μmol/L; Figure 4). Relatively high αT concentrations in 
adipose tissue was reported before [13, 16, 28]; and was explained by the comparably low 
turnover of adipocytes, which slowly accumulate and release αT [16, 29]. Adipose tissue was 
also reported as the main storage for α- and γ- tocotrienols and MDT [14, 16, 18, 28, 30]. 
As expected, deletion of the Ttpa gene in mice resulted in almost complete depletion of αT 
from tissues and blood (Figure 3), highlighting its importance for the maintenance of an 
adequate αT status, as previously reported [7, 13, 22, 31]. In agreement with our 
understanding of the role of TTP in mediating the selective secretion of αT from the liver into 
the bloodstream [6], αT concentrations in the small intestine were not under the control of 
TTP and therefore similar in TTP+/+ and TTP-/- mice. 
Interestingly, αT1 was numerically reduced in the blood of TTP-/- mice, but contrary to αT, it 
was still present in the blood (Figure 4). Earlier observations reported a TTP-independent 
distribution of α-tocotrienol into the bloodstream [15]. Nevertheless, our results cannot rule 
out that TTP is involved in the distribution of αT1. The observed reduction in αT1 
concentrations in the blood of TTP-/- mice suggest that αT1 may not require TTP activity to 
the same extent as αT for the secretion into the blood (Figure 3H), but there may still be a 
TTP-influence on αT1 bioavailability. 
Overall, αT concentrations in tissues were ca. 10-fold lower than the values reported in tissues 
of mice and rats fed diets containing 30-100 mg αT per kg diet [7, 13, 16, 18, 28]. These low 
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αT concentrations in tissues are more similar to values reported in mice and rats after feeding 
of αT-deficient or αT-free diets [16, 28, 32]. 
The unexpected depletion of αT and αT1 in the livers of our mice was confirmed by GC/MS 
analyses (see Supplementary Figure 2, data interpretation based on previous publication [24]). 
It was previously reported that αT is secreted from the liver at a higher rate, thus possibly 
depleting the liver of αT, when the intake of the vitamin is inadequate [29, 33]. A complete 
reduction of αT in the liver was reported before in TTP-/- mice fed a vitamin E-depleted diet 
from the age of 3 to 18 months [31], for male Wistar rats fed a diet containing < 0.4 μg/g αT 
for 6 weeks followed by an αT-free diet for 7 days [28]; and an almost complete depletion of 
αT in the liver was observed in male Fisher 344 rats after 6 months feeding with an αT-
deficient diet [34], as well as in male Wistar rats fed a vitamin E-free diet from 6 until 10 
weeks old [16].  
The low αT concentrations in tissues and the depletion of αT and αT1 in the livers made us 
questioning about the integrity of the vitamin E in the experimental diets. It is possible that 
the vitamin E added to vitamin E-free corn oil to prepare our experimental diets was rapidly 
oxidized and the final concentrations in the diets might thus have been significantly lower 
than planned. We therefore retrospectively measured the concentrations of αT and αT1 in the 
experimental diets, which were supposed to be 30 mg/kg, but indeed were ≤ 1 mg/kg diet 
(Supplementary Figure 1). 
Even though we cannot currently rule out alternative explanations, it is possible that the low 
intake of αT in our animals led to a redistribution of αT from the liver to peripheral tissues, 
resulting in the observed depletion of vitamin E from this organ and the lower values in the 
other tissues.  
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4. Conclusion 
 
In conclusion, we report, for the first time, the absorption of αT1 into the blood of mice. 
Contrary to αT, αT1 was still found in the blood of mice not expressing TTP, but at lower 
concentrations than in wild-type mice. These results suggest that αT1 secretion from the liver 
may not depend to the same extent as αT on the function of TTP, but may still be partly 
controlled by it. 
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Figure 1. Chemical structures of α-tocopherol and α-tocomonoenol. 
 
 
 
 
 
 
 
 
Figure 2. Representative Western blots of hepatic α-tocopherol transfer protein expression in 
TTP+/+ and TTP-/- mice (n=11) used in the feeding trial. 
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Figure 3. Mean tissue concentrations (error bars represent standard error of the mean; n = 11) 
of αT in TTP+/+ and TTP-/- mice fed a standard diet with either αT or αT1 for 2 weeks. Bars 
not sharing a common letter are significantly different at P<0.05.  
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Figure 4. Mean whole blood concentration (error bars represent standard error of the mean; n 
= 11) of αT1 in TTP+/+ and TTP-/- mice fed a standard diet with either αT or αT1 for 2 weeks. 
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Supplementary Figure 1. Mean concentrations (error bars represent standard error of the 
mean; n = 3) of vitamin E in the breeding (A), special vitamin (B) and experimental (C) foods 
fed the TTP+/+ and TTP-/- mice during their life. The breeding food is produced by ssniff 
Spezialdiaeten GmbH (Soest, Germany) and the special vitamin and experimental diet are 
produced by Altromin Spezialfutter GmbH & Co (KG, Lage, Germany). 
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Supplementary Figure 2. Representative GC/MS chromatograms (full scan mode) of the 
analyzed liver extracts of TTP+/+ and TTP-/- mice fed a standard diet with either αT (A and 
B, respectively) or αT1 (C and D, respectively) for 2 weeks. Peaks from 10-12 minutes belong 
to free fatty acids (FFA), peak at 19 minute is the internal standard (IS) 5-alpha-cholestane 
and the slight peak at 26 minute corresponds to cholesterol. αT and αT1 were reported to 
appear at 24 and 25 minutes, respectively, and their absences were noted in all experimental 
groups. 
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Chapter 5 
Concluding discussion 
 
The present thesis aimed at increasing our knowledge of the non-αT congeners of vitamin E 
with respect to their occurrence in food, their intracellular localization upon uptake into liver 
cells, and their tissue distribution in mammals. Because the intracellular localization and 
tissue distribution of the main vitamin E congener αT is under the control of the hepatic TTP, 
the role of this protein in the intracellular and intra-organismic trafficking of the non- αT 
congeners was a second focus of the current investigations.  
The first aim of the thesis, namely to determine the vitamin E profiles of Costa Rican palm 
oils, was the basis for the subsequent aims and experiments. The Ph. D. project started with an 
inventory of the vitamin E profile and content in oils of Costa Rican Palm fruits. To this end, 
six varieties and two extraction procedures were studied. The used varieties belong to the 
Elaeis species with industrial importance in the palm oil market of Costa Rica and were 
selected in cooperation with ASD Costa Rica Breeding Division. In total, three Elaeis 
Guineensis, two Elaeis Oleifera and one interspecific hybrid varieties were selected for 
detailed analyses. 
The two oil extraction techniques selected, chemical and mechanical extraction, are the two 
most common and commercially relevant extraction procedures. Chemical extraction mainly 
uses hexane as a solvent, which extracts the majority of lipids and thus has a higher oil yield 
than mechanical extractions. A disadvantage is the co-extraction of unwanted artifacts, such 
as waxes, which compromises the oil quality. The required subsequent purification process to 
ensure a complete removal of solvent residues in the oil is time- consuming, costly and 
environmentally unfriendly. Mechanical extraction is therefore the preferred procedure in the 
palm oil industry, even though the oil yield is lower than chemical extraction, the procedure is 
cleaner, cheaper, and less time-consuming [57, 58]. 
The obtained results (Chapter 2) demonstrated that in all varieties and irrespective of the 
extraction procedure, α- and γ-tocotrienols were the most abundant congeners in Costa Rican 
palm oils. Oils from five of the six palm varieties also contained α-tocomonoenol, one of the 
more recently discovered vitamin E derivatives bearing a single double bond at carbon 11' 
(Chapter 2). 
Once the two most abundant tocotrienols (αT3 and γT3) were identified during the 
characterization of the oils, they were selected for further studies with respect to their cellular 
uptake and intracellular distribution in cultured liver cells. This second aim of the thesis 
addressed, for the first time, the intracellular trafficking of these compounds and compared 
them to their respective tocopherol counterparts (αT and γT). In order to elucidate whether or 
not the TTP is involved in the intracellular trafficking of these vitamin E congeners, a human 
hepatoma cell line (HepG2) expressing TTP was used for the experiments and compared to 
the parent HepG2 clone not expressing TTP. An optimized method of subcellular 
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fractionation with self-generated gradients of Iodixanol, an iodinated density gradient media 
capable of organelles isolations of 80-90% yield and high purity [59], was used and 
reproducibility of the separation was monitored with the density of the Iodixanol (Chapter 3). 
αT1, which was detected in the Costa Rican Palm oils, was also reported in other fruits and 
oils (see introduction). There is, however, a lack of studies regarding its behavior in vivo. The 
third aim of the thesis was therefore to characterize the tissue distribution of αT1 in mice in 
comparison to αT and to investigate the influence of TTP (Chapter 4). To this end, a rodent 
model with mice deficient in TTP (TTP-/-) and TTP-expressing wild type (TTP+/+) mice was 
used. An animal model was required to study tissue distribution, but also because the 
metabolic enzymes in the liver (CYP, enzymes of β-oxidation) and TTP in combination with 
the enzyme systems in other organs, such as the small intestine and kidney, control the flow 
of vitamin E in the body and its excretion [60].  
The main results of the present thesis are summarized below: 
 
Characterization of vitamin E profile in oils of Costa Rican Palm fruits extracted by 
chemical and mechanical extraction 
▪ All eight vitamin E congeners, α-, β-, γ- and δ-tocopherols and -tocotrienols, and α-
tocomonoenol were detected in the six varieties of palm oils extracted (E. Guineensis 
Tanzania, E. Guineensis Deli Dami, E. Guineensis Deli x Nigeria, E. Oleifera Quepos, 
E. Oleifera Manaos and Hybrid OxG). 
▪ The concentrations of the vitamin E congeners in the oils were in the order of γT3 > 
αT3 > δT3 > αT ≥ βT3 > γT ≈ βT ≈ δT among the studied varieties, irrespective of the 
genotype and extraction procedure. 
▪ Total vitamin E content of the palm oils is almost entirely made up of tocotrienols 
(>91%), and the genotype Quepos had by far the highest total vitamin E content, 
which consisted of 99.8% tocotrienols. 
▪ Total vitamin E content ranged from 163-525 μg/g for the Elaeis Guineensis, 254-892 
μg/g for the Elaeis Oleifera and 222-471 μg/g for the Hybrid OxG. 
▪ Hexane extraction yielded up to 2.5-fold higher total vitamin E compared to screw 
press extraction (hexane extraction, 333-892 μg/g; screw press extraction, 163-624 
μg/g); and the differences in the vitamin E extraction efficiencies were due to vitamin 
E losses in the byproducts (residual peel, residual press cake, centrifugation 
byproduct). 
▪ The αT1 contents of the analyzed oils were, irrespective of the extraction method, in 
the order E. Guineensis Tanzania (3.0-2.73 μg/g) > Hybrid OxG (0.59-1.39 μg/g) = E. 
Guineensis Deli x Nigeria (0.677-0.85 μg/g) > E. Oleifera Quepos (0.20-0.42 μg/g) = 
Manaos (0.18-0.48 μg/g) > E Guineensis Deli Dami (n.d.-0.078 μg/g). 
▪ In standard reversed-phase HPLC analyses, αT1 eluted between βT and γT and partly 
overlapped with the latter. A co-elution of the αT1 with γT was observed for the 
pumpkin seed oil, which is characterized by its high content of γT (63.5%). This co-
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elution may thus, particularly when αT1 is present at appreciable concentrations, lead 
to an overestimation of the γT content of foods. 
As detailed in Chapter 2, the concentrations and relative abundances of the tocotrienols and 
tocopherols in the palm oils analyzed are in agreement with previous studies, even though the 
values are subject to large variability. Tocotrienols are by far the most abundant 
tocochromanols in the palm oils. Vitamin E congeners identified in the palm oils are the same, 
irrespective of the genotype and extraction procedure, and although the order of abundance of 
the congeners follows the same path for all genotypes, their total concentration and as 
consequence the total vitamin E content varies. The fact that total vitamin E was overall in the 
order of Elaeis Oleifera ≥ Hybrid OxG ≥ Elaeis Guineensis supports the genetic background 
inherent to the varieties. Elaeis Oleifera has a higher content of vitamin E than the Elaeis 
Guineensis, and through the hybridization, the breeders aimed at achieving a variety with a 
vitamin E content between the Elaeis Guineensis and Elaeis Oleifera [61].  
The observation that the differences in the vitamin E yields between extractions are caused by 
losses with the extraction byproducts, established the importance of the maximum utilization 
of the fruit parts during processing. As mentioned in Chapter 2, reported concentrations of 
vitamin E retained in the palm fruit fiber are 2-fold higher than the concentrations in the crude 
oil. Chemical extraction can be improved by extracting the peel together with the mesocarp 
and mechanical extraction can be enhanced by changing to hydraulic press and adding water 
during the pressing process, enhancing the leaching of the oil out of the press cake [58]. The 
design of the screw press allows the entrapment of fruit debris in the equipment, reducing the 
oil released. 
The obtained results of this first part of the project support the importance of palm oil as one 
of the few good sources of tocotrienols. Tocotrienols have many health beneficial activities 
(e.g. antioxidant, hypocholesterolemic agent) and may have a role in the prevention of 
degenerative diseases, including cardiovascular and age-related diseases and cancer [12]. As 
palm oil tree is the sixth major crop cultivated in Costa Rica [62], its promotion among 
agricultural and food industries may contribute to ensuring food security in Costa Rica. 
 
The role of the α-tocopherol transfer protein in the cellular uptake and intracellular 
distribution of α- and γ-tocotrienols 
▪ Tocotrienols were taken up by the cells faster than the tocopherols and the γ-congeners 
more than the α-congeners, irrespective of the expression of TTP, initially suggesting 
that the methylation of the chromanol ring and the sidechain saturation are important 
factors on the cellular uptake. 
▪ A steady uptake into the cells over time was observed until 24 h, afterwards the 
concentrations slightly declined, suggesting the start of the metabolic degradation of 
the congeners. 
▪ A significant instability of the congeners in the order of αT > αT3 > γT3 > γT was 
observed in the cell culture medium upon addition and further declines were observed 
after 30 minutes. This questioned if the observed trend in the cellular absorption of the 
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congeners is due to differences in the cellular uptake and suggested that the true 
reason may be differences in the stability of the vitamin E congeners in the medium. 
▪ Intracellular distribution indicated that, irrespective of TTP-expression in liver cells, 
the four congeners correlated mainly with the markers for the endoplasmic reticulum, 
plasma membrane, and lysosomes, but not with those for the peroxisomes, and only 
αT correlated with mitochondria. 
▪ The only influence of the TTP on the intracellular distribution was observed for the 
localization of the γT in peroxisomes, which negatively correlated with the organelle 
in the presence of the protein, suggesting a prevention of the transport of γT to 
peroxisomes, and therefore to its metabolism. 
▪ TTP expression correlated mainly with the organelle markers for the endoplasmic 
reticulum, plasma membrane and lysosomes, which is in agreement with the 
understanding of its trafficking in hepatocytes and its role in preventing vitamin E 
metabolism. 
The results obtained in this cell culture experiment revealed that the structural differences 
(chromanol ring methylation pattern or sidechain saturation) between αT, αT3, γT3 and γT are 
not important factors behind the cellular uptake and intracellular distribution, since no 
significant differences were observed between congeners. The results further demonstrate that 
the expression of the TTP does not regulate the intracellular trafficking (uptake and 
distribution) of the congeners in the cultured liver cells. 
Even though in the early stage of the cellular uptake experiments, the T3 and γ-congeners 
were apparently taken up faster, the fact that the faster increase of the T3 in cells were not 
accompanied by a faster decrease in T3 concentrations in culture medium, gave the idea that 
the differences in uptake might be due to a stability problem of the T over T3 rather than a 
better uptake of T3. 
As discussed in the Chapter 3, an increased uptake of the T3 over T was reported before in 
other cell culture models, and was attributed to the higher intermembrane mobility of the T3. 
However, the instability of the studied congeners directly upon addition and afterwards in the 
culture medium does not allow stating an effect of the chemical structure in the cellular 
uptake. Possible explanations behind the lack of stability of the congeners are summarized in 
Chapter 3. In future experiments, it would be important to improve the stability of the 
compounds in the culture medium before conducting the cultured experiments, for example 
by using different solvents to dissolve the compounds and/or adding antioxidants to the 
medium (e.g. vitamin C and butylated hydroxytoluene). 
The lack of influence of TTP on cellular uptake of the congeners was not unexpected. It had 
been reported before that other proteins, the low-density lipoprotein receptor-related protein 
(LRP) or the scavenger receptor class B type I (SR-BI) mediate the uptake of vitamin E into 
hepatocytes [63, 64]. 
The observed intracellular distribution of the congeners and of TTP among the organelles is in 
line with the understanding of the intracellular trafficking of αT. When αT enters the 
hepatocyte, it is transported to the late endosome (e.g. lysosomes), where TTP translocates 
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from the cytosol to mediate αT transport from the late endosomes to the plasma membrane. 
Then the protein interacts with phosphatidylinositol 4,5-bisphosphate (PIP2) in the plasma 
membrane, which causes a conformational change that releases αT into the plasma membrane. 
Once released, αT exits the plasma membrane through an ABC-type transporter. TTP 
translocates again to αT-containing organelles to repeat the cycle [20, 43]. 
The positive correlations of the intracellular congener concentrations with the endoplasmic 
reticulum and lack of correlation with the peroxisomes and mitochondria (except for αT) 
agree with the function of these organelles in vitamin E metabolism. These are the sites where 
the first, second, and third steps in the metabolism of vitamin E occur (see Chapter 3). 
Congeners are present in the endoplasmic reticulum at the beginning of the degradation, but 
afterwards the metabolites rather than the parent compounds are expected to localize in the 
peroxisomes and mitochondria. 
The positive correlation of TTP with the endoplasmic reticulum and the negative correlation 
of γT with the peroxisomes in the presence of TTP, suggest a role of the protein in the 
metabolism of the congeners, in particular γT. As reported before, in cultured cells TTP 
reduced the metabolism of γT, suggesting that binding of the non-αT congeners to TTP 
partially protects their side-chain from ω-hydroxylation (first degradation reaction) [44]. 
The results obtained during this part of the project gave novel insights into the intracellular 
sites where the non-αT congeners reside and thus provides novel opportunities for the 
investigation of potential biological activities of these compounds in these organelles. The 
finding that TTP lacks a significant role in the uptake and intracellular distribution of the 
vitamin E congeners supports previous findings that stablished TTP is involved in the 
secretion of mainly αT from the liver cells. As described in Chapter 3, simple passive 
diffusion or organelle-lipid content can be driving forces behind the distribution of the 
congeners within the cell. 
 
The role of the α-tocopherol transfer protein in the tissue and blood distribution of α-
tocomonoenol 
▪ αT1 was only found in blood, not in tissues, in wild-type (TTP+/+) mice at a 
concentration of 0.186 ± 0.079 μmol/L, approximately 40% of the concentration of αT 
in the blood of the same type of mice. 
▪ Accumulation of αT in wild-type (TTP+/+) mice was in the order of adipose tissue > 
brain > heart > spleen > lungs > kidneys > small intestine > liver (from 2.48 ± 0.41 
nmol/g in adipose tissue to undetectable in liver) and reached 0.560 ± 0.065 μmol/L in 
blood. 
▪ Deletion of the TTP in knockout (TTP-/-) mice resulted in almost complete depletion 
of αT in tissues and blood, with the exception of the small intestine, whereas no 
significant differences in αT concentrations were observed between the TTP+/+ and 
TTP-/- mice. 
▪ αT1 concentrations in blood of TTP-/- mice did not significantly differ from TTP+/+ 
mice, but were numerically lower (ca. 25% of the concentration in TTP+/+ mice). 
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Differences in the tissue and blood distribution of the αT1 compared to αT were observed. 
αT1 is bioavailable and reaches the blood in mice, but does not accumulate in tissues.  
Contrary to αT, αT1 was still detectable in the blood of TTP-/-, suggesting that TTP may not, 
or only to a limited extent, be required for the secretion of αT1 into the systemic circulation. 
The third part of the project gave, for the first time, insights into the overall tissue distribution 
of αT1, and how it can be influenced by the presence of TTP. Just one study was performed 
earlier on the accumulation of αT1 in liver, brain, spleen and lung of wild-type mice fed 2 
weeks with a vitamin E extract from tuna oil, containing αT1, MDT, αT, βT, γT and δT. This 
study reported the presence of αT1 in liver and brain, not in spleen and lung [65]. However, 
the study has some loopholes. The exact αT1 dose administered is not clearly stated; instead 
the authors only gave the relative distribution of the different congeners in the feed. 
Therefore, the results of the tissue accumulation are limited and difficult to compare. The 
reported absolute concentration of the αT1 in the mouse tissues remains unclear. The novelty 
of our present research was the use of ≥ 99.5% pure αT1 instead of a vitamin E mixture, 
which ruled out possible influences of the co-ingestion of the other congeners on the 
bioavailability of αT1. We furthermore gave a more comprehensive overview of the tissue 
distribution, by analyzing a larger number of tissues. 
TTP-/- mice are a valuable model to investigate the role of the protein on vitamin E trafficking 
and were successfully employed, as can be seen from the expected and observed depletion of 
αT from tissues and blood in the TTP-/- mice. The fact that TTP did not control the 
concentrations of αT in the small intestine is in agreement with its lack of involvement in the 
uptake of vitamin E into cells (see also Chapter 3) and its role in the liver, namely facilitating 
the secretion of αT into the blood (see also the discussion in Chapter 4). Regarding the 
importance of TTP for regulating αT1 concentrations, the current study is inconclusive. The 
fact that αT1, but not the TTP-ligand with the highest affinity, αT, was detectable in the blood 
of TTP-/- mice, suggests that TTP might not be required or importantly involved in its 
secretion. On the other hand, the blood concentrations of αT1 in TTP-/- mice were only ca. 
25% of those measured in wildtype mice, which could be seen as evidence for a role of TTP 
in the secretion. 
One of the biggest surprises observed during this experiment was the lack of αT in the liver of 
the mice, which was confirmed by GC-MS analysis. Therefore, we analyzed the 
concentrations of αT in the different diets fed to the mice during their life (the standard 
maintenance diet used in the colony, the high-αT diet used for breeding of TTP-/- mice, and 
the experimental diets) and found vitamin E values below the expected ones and in the range 
from marginal to deficient αT consumption (see discussion on Chapter 4). This undesired 
loss of αT in the foods during the experiment might explain the observed results in the liver of 
both mice genotypes. As explained in Chapter 4, a similar depletion of αT from the liver was 
observed before when diets deficient in αT were fed to rodents. The lack of dietary vitamin E 
might induce its acquisition from liver stores and secretion into the blood to satisfy αT 
requirements of the extrahepatic tissues. 
We also observed a degradation of αT1 in the experimental diets, which might have 
contributed to the lack of accumulation of αT1 in the tissues. However, the observed presence 
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of αT1 in blood, despite the low content of the diet, is a promising result, as the bioavailability 
of αT1 is a requirement for further studies into any potential biological activities and health 
benefits.  
 
Accomplishments and future research opportunities 
Overall, the present thesis accomplished the aim of increasing our knowledge regarding food 
sources for the non-αT congeners αT3, γT3 and αT1 and their processing, intracellular 
trafficking, and in vivo tissue distribution in mice. 
A first report on the vitamin E profile of oils from Costa Rican palm fruits and of αT1 
concentrations in these varieties was achieved. Of particular interest is that the non-αT 
congeners represent the majority of vitamin E in this oil (see Chapter 1). A broader screening 
of potential food sources of non-αT congeners, especially αT1, should focus on lipid-rich 
foods not yet characterized, but consumed or underutilized, i.e. seed oils, algae, green leafy 
vegetables, and marine products. 
Besides, the project described for the first time the cellular uptake and intracellular 
distribution of αT3 and γT3 in hepatic cells, and the tissue and blood distribution of αT1 in 
mice. The use of cultured cells and animal models capable of an expression, or not, of the 
TTP added value to the research, since the potential role of this protein in the trafficking of 
the non-αT congeners was addressed for the first time. 
The research of the intracellular distribution of αT, γT αT3 and γT3 in hepatic cells can be 
complemented with the further analyses of the metabolites in the different organelles. 
Metabolites are expected in the endoplasmic reticulum, peroxisomes and mitochondria. 
However, their concentrations in the organelles and to which extent they are controlled by 
TTP are unknown. 
For αT1, there are plenty of future research opportunities due to the novelty of the congener 
and scarceness of related scientific publications. Experiments on the cellular uptake and 
intracellular distribution in hepatic cells, comparable to the one performed for αT, γT αT3 and 
γT3, are necessary to understand its intracellular trafficking and whether or not the TTP is 
required for its secretion from the cells. Another interesting contribution on the research 
towards αT1 would be the measurement of the affinity of TTP for αT1, because previous 
investigations observed an influence of TTP affinities for the vitamin E congeners on their 
distribution in extrahepatic tissues and metabolism [39] 
In continuation of the results obtained in the mouse trial (Chapter 4), further studies 
investigating the dose-response of the absorption of αT1 in TTP-/- mice might be required to 
clarify if TTP is involved in the secretion of αT1 into the bloodstream. Furthermore, a trial 
feeding mice with αT1-depleted, –standard, or –supplemented diets would be important to 
conclusively study the tissue distribution and potential dose-responses on the absorption of 
αT1. A trial employing different dietary doses also allows the measure of indicators of 
vitamin E activity (e.g. HO-1 and CD36 protein expression), with which effects were 
previously observed using diets with αT [54, 55]. 
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To conclude, studies on the metabolism of αT1 are highly warranted. It was pointed out 
before that the unsaturated side-chain of the tocotrienols is metabolized by enzymes involved 
in the metabolism of unsaturated fatty acids. Three enzymes, the 2,4-dienoyl-coenzyme A 
reductase, 3,2-enoyl-coenzime A isomerase and enoyl-coenzime A hydratase, work together 
in saturating the double bonds one by one, starting from the end of the side-chain [22]. If the 
side-chain of the αT1 can be saturated similar to that of the tocotrienols, this could lead to its 
conversion into αT or into the long-chain metabolites of αT. αT and its long-chain metabolites 
are known for their biological activities and health benefits (see Chapter 1), and a potential 
conversion of the αT1 gives an interesting twist on the essentiality of this congener. 
In general, significantly more is known about αT compared to any of the non-αT congeners. 
Based on the contributions of the present thesis to the scientific progress, new opportunities 
for future research on the biological activities and potential health-benefits of the non-αT 
congeners have arisen. 
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